SE544611C2 - Polymer particles - Google Patents
Polymer particlesInfo
- Publication number
- SE544611C2 SE544611C2 SE1830166A SE1830166A SE544611C2 SE 544611 C2 SE544611 C2 SE 544611C2 SE 1830166 A SE1830166 A SE 1830166A SE 1830166 A SE1830166 A SE 1830166A SE 544611 C2 SE544611 C2 SE 544611C2
- Authority
- SE
- Sweden
- Prior art keywords
- group
- mixing
- chz
- water
- particles
- Prior art date
Links
- 239000002245 particle Substances 0.000 title claims abstract description 154
- 229920000642 polymer Polymers 0.000 title claims abstract description 73
- 238000000034 method Methods 0.000 claims abstract description 44
- 239000000203 mixture Substances 0.000 claims abstract description 44
- 239000000178 monomer Substances 0.000 claims abstract description 34
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims abstract description 34
- 125000000524 functional group Chemical group 0.000 claims abstract description 15
- 238000013019 agitation Methods 0.000 claims abstract description 10
- 239000003381 stabilizer Substances 0.000 claims abstract description 10
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 9
- 239000004094 surface-active agent Substances 0.000 claims abstract description 9
- 239000002270 dispersing agent Substances 0.000 claims abstract description 6
- 239000001257 hydrogen Substances 0.000 claims abstract description 5
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 5
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims abstract description 5
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims abstract 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 105
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 71
- 238000002156 mixing Methods 0.000 claims description 58
- 238000006116 polymerization reaction Methods 0.000 claims description 57
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 24
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 20
- -1 phosphino group Chemical group 0.000 claims description 19
- 239000002904 solvent Substances 0.000 claims description 16
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 14
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 12
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 claims description 10
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 7
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 6
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 claims description 6
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 6
- XPFVYQJUAUNWIW-UHFFFAOYSA-N furfuryl alcohol Chemical compound OCC1=CC=CO1 XPFVYQJUAUNWIW-UHFFFAOYSA-N 0.000 claims description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 6
- OXBLVCZKDOZZOJ-UHFFFAOYSA-N 2,3-Dihydrothiophene Chemical compound C1CC=CS1 OXBLVCZKDOZZOJ-UHFFFAOYSA-N 0.000 claims description 5
- 125000003277 amino group Chemical group 0.000 claims description 5
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 4
- JYVLIDXNZAXMDK-UHFFFAOYSA-N pentan-2-ol Chemical compound CCCC(C)O JYVLIDXNZAXMDK-UHFFFAOYSA-N 0.000 claims description 4
- AQIXEPGDORPWBJ-UHFFFAOYSA-N pentan-3-ol Chemical compound CCC(O)CC AQIXEPGDORPWBJ-UHFFFAOYSA-N 0.000 claims description 4
- 238000010526 radical polymerization reaction Methods 0.000 claims description 4
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 claims description 4
- 238000010146 3D printing Methods 0.000 claims description 3
- 125000000751 azo group Chemical group [*]N=N[*] 0.000 claims description 3
- 238000006243 chemical reaction Methods 0.000 claims description 3
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 230000003068 static effect Effects 0.000 claims description 3
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 claims description 2
- BTANRVKWQNVYAZ-SCSAIBSYSA-N (2R)-butan-2-ol Chemical compound CC[C@@H](C)O BTANRVKWQNVYAZ-SCSAIBSYSA-N 0.000 claims description 2
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 claims description 2
- JHUUPUMBZGWODW-UHFFFAOYSA-N 3,6-dihydro-1,2-dioxine Chemical compound C1OOCC=C1 JHUUPUMBZGWODW-UHFFFAOYSA-N 0.000 claims description 2
- 239000004386 Erythritol Substances 0.000 claims description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims description 2
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 claims description 2
- UWHCKJMYHZGTIT-UHFFFAOYSA-N Tetraethylene glycol, Natural products OCCOCCOCCOCCO UWHCKJMYHZGTIT-UHFFFAOYSA-N 0.000 claims description 2
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 claims description 2
- 239000006185 dispersion Substances 0.000 claims description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims description 2
- 235000019414 erythritol Nutrition 0.000 claims description 2
- 229940009714 erythritol Drugs 0.000 claims description 2
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 claims description 2
- JLFNLZLINWHATN-UHFFFAOYSA-N pentaethylene glycol Chemical compound OCCOCCOCCOCCOCCO JLFNLZLINWHATN-UHFFFAOYSA-N 0.000 claims description 2
- XLMFDCKSFJWJTP-UHFFFAOYSA-N pentane-2,3-diol Chemical compound CCC(O)C(C)O XLMFDCKSFJWJTP-UHFFFAOYSA-N 0.000 claims description 2
- GTCCGKPBSJZVRZ-UHFFFAOYSA-N pentane-2,4-diol Chemical compound CC(O)CC(C)O GTCCGKPBSJZVRZ-UHFFFAOYSA-N 0.000 claims description 2
- 229920000166 polytrimethylene carbonate Polymers 0.000 claims description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 2
- 238000009210 therapy by ultrasound Methods 0.000 claims description 2
- 125000003172 aldehyde group Chemical group 0.000 claims 2
- IVRMZWNICZWHMI-UHFFFAOYSA-N azide group Chemical group [N-]=[N+]=[N-] IVRMZWNICZWHMI-UHFFFAOYSA-N 0.000 claims 2
- 125000005621 boronate group Chemical group 0.000 claims 2
- 125000001626 borono group Chemical group [H]OB([*])O[H] 0.000 claims 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 2
- 150000007942 carboxylates Chemical group 0.000 claims 2
- XLJMAIOERFSOGZ-UHFFFAOYSA-M cyanate group Chemical group [O-]C#N XLJMAIOERFSOGZ-UHFFFAOYSA-M 0.000 claims 2
- 125000004185 ester group Chemical group 0.000 claims 2
- 125000005843 halogen group Chemical group 0.000 claims 2
- NHNBFGGVMKEFGY-UHFFFAOYSA-N nitrate group Chemical group [N+](=O)([O-])[O-] NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 claims 2
- 125000002560 nitrile group Chemical group 0.000 claims 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 2
- 125000000018 nitroso group Chemical group N(=O)* 0.000 claims 2
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 claims 2
- 125000004076 pyridyl group Chemical group 0.000 claims 2
- 125000000213 sulfino group Chemical group [H]OS(*)=O 0.000 claims 2
- 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 claims 2
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 claims 2
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims 2
- 150000007970 thio esters Chemical group 0.000 claims 2
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M thiocyanate group Chemical group [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 claims 2
- 125000005323 thioketone group Chemical group 0.000 claims 2
- 125000003368 amide group Chemical group 0.000 claims 1
- 230000003190 augmentative effect Effects 0.000 claims 1
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 1
- 125000005462 imide group Chemical group 0.000 claims 1
- 125000000879 imine group Chemical group 0.000 claims 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M nitrite group Chemical group N(=O)[O-] IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 claims 1
- 125000003544 oxime group Chemical group 0.000 claims 1
- 125000001476 phosphono group Chemical group [H]OP(*)(=O)O[H] 0.000 claims 1
- 230000002269 spontaneous effect Effects 0.000 claims 1
- 125000000101 thioether group Chemical group 0.000 claims 1
- 125000003396 thiol group Chemical group [H]S* 0.000 claims 1
- 238000002360 preparation method Methods 0.000 abstract description 8
- 239000000243 solution Substances 0.000 description 56
- 239000012071 phase Substances 0.000 description 26
- HVVWZTWDBSEWIH-UHFFFAOYSA-N [2-(hydroxymethyl)-3-prop-2-enoyloxy-2-(prop-2-enoyloxymethyl)propyl] prop-2-enoate Chemical compound C=CC(=O)OCC(CO)(COC(=O)C=C)COC(=O)C=C HVVWZTWDBSEWIH-UHFFFAOYSA-N 0.000 description 21
- 238000002835 absorbance Methods 0.000 description 20
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 19
- 238000002296 dynamic light scattering Methods 0.000 description 18
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 17
- 229960005419 nitrogen Drugs 0.000 description 17
- 229910001873 dinitrogen Inorganic materials 0.000 description 15
- 239000000523 sample Substances 0.000 description 15
- OZAIFHULBGXAKX-VAWYXSNFSA-N AIBN Substances N#CC(C)(C)\N=N\C(C)(C)C#N OZAIFHULBGXAKX-VAWYXSNFSA-N 0.000 description 14
- 239000004698 Polyethylene Substances 0.000 description 13
- 239000003999 initiator Substances 0.000 description 13
- 239000003814 drug Substances 0.000 description 12
- 229940079593 drug Drugs 0.000 description 11
- 230000006911 nucleation Effects 0.000 description 11
- 238000010899 nucleation Methods 0.000 description 11
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 10
- JOBBTVPTPXRUBP-UHFFFAOYSA-N [3-(3-sulfanylpropanoyloxy)-2,2-bis(3-sulfanylpropanoyloxymethyl)propyl] 3-sulfanylpropanoate Chemical compound SCCC(=O)OCC(COC(=O)CCS)(COC(=O)CCS)COC(=O)CCS JOBBTVPTPXRUBP-UHFFFAOYSA-N 0.000 description 9
- 238000001212 derivatisation Methods 0.000 description 9
- 238000009826 distribution Methods 0.000 description 9
- 238000010587 phase diagram Methods 0.000 description 9
- 229920001223 polyethylene glycol Polymers 0.000 description 9
- 238000010532 solid phase synthesis reaction Methods 0.000 description 9
- RSROEZYGRKHVMN-UHFFFAOYSA-N 2-ethyl-2-(hydroxymethyl)propane-1,3-diol;oxirane Chemical compound C1CO1.CCC(CO)(CO)CO RSROEZYGRKHVMN-UHFFFAOYSA-N 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- 238000003384 imaging method Methods 0.000 description 8
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 7
- 230000008878 coupling Effects 0.000 description 7
- 238000010168 coupling process Methods 0.000 description 7
- 238000005859 coupling reaction Methods 0.000 description 7
- 238000004132 cross linking Methods 0.000 description 7
- 238000000605 extraction Methods 0.000 description 7
- 238000011534 incubation Methods 0.000 description 7
- 239000003446 ligand Substances 0.000 description 7
- 125000005647 linker group Chemical group 0.000 description 7
- 229910052757 nitrogen Inorganic materials 0.000 description 7
- 239000011541 reaction mixture Substances 0.000 description 7
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- VFFFESPCCPXZOQ-UHFFFAOYSA-N 2,2-bis(hydroxymethyl)propane-1,3-diol;oxirane Chemical compound C1CO1.OCC(CO)(CO)CO VFFFESPCCPXZOQ-UHFFFAOYSA-N 0.000 description 4
- MQUMNTKHZXNYGW-UHFFFAOYSA-N 2-ethyl-2-(hydroxymethyl)propane-1,3-diol;propane-1,3-diol Chemical compound OCCCO.CCC(CO)(CO)CO MQUMNTKHZXNYGW-UHFFFAOYSA-N 0.000 description 4
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 4
- IRQWEODKXLDORP-UHFFFAOYSA-N 4-ethenylbenzoic acid Chemical compound OC(=O)C1=CC=C(C=C)C=C1 IRQWEODKXLDORP-UHFFFAOYSA-N 0.000 description 4
- OKKRPWIIYQTPQF-UHFFFAOYSA-N Trimethylolpropane trimethacrylate Chemical compound CC(=C)C(=O)OCC(CC)(COC(=O)C(C)=C)COC(=O)C(C)=C OKKRPWIIYQTPQF-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 239000002872 contrast media Substances 0.000 description 4
- 238000012674 dispersion polymerization Methods 0.000 description 4
- 229940093476 ethylene glycol Drugs 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 230000000977 initiatory effect Effects 0.000 description 4
- 239000000693 micelle Substances 0.000 description 4
- 239000007790 solid phase Substances 0.000 description 4
- 229920002554 vinyl polymer Polymers 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 3
- 125000002091 cationic group Chemical group 0.000 description 3
- 150000004662 dithiols Chemical class 0.000 description 3
- 239000003937 drug carrier Substances 0.000 description 3
- 238000007720 emulsion polymerization reaction Methods 0.000 description 3
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 3
- 238000012673 precipitation polymerization Methods 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 235000013772 propylene glycol Nutrition 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 238000010557 suspension polymerization reaction Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 2
- BDNKZNFMNDZQMI-UHFFFAOYSA-N 1,3-diisopropylcarbodiimide Chemical compound CC(C)N=C=NC(C)C BDNKZNFMNDZQMI-UHFFFAOYSA-N 0.000 description 2
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 2
- ZCHGODLGROULLT-UHFFFAOYSA-N 2,2-bis(hydroxymethyl)propane-1,3-diol;propane-1,2-diol Chemical compound CC(O)CO.OCC(CO)(CO)CO ZCHGODLGROULLT-UHFFFAOYSA-N 0.000 description 2
- ZMZGFLUUZLELNE-UHFFFAOYSA-M 2,3,5-triiodobenzoate Chemical compound [O-]C(=O)C1=CC(I)=CC(I)=C1I ZMZGFLUUZLELNE-UHFFFAOYSA-M 0.000 description 2
- KUDUQBURMYMBIJ-UHFFFAOYSA-N 2-prop-2-enoyloxyethyl prop-2-enoate Chemical compound C=CC(=O)OCCOC(=O)C=C KUDUQBURMYMBIJ-UHFFFAOYSA-N 0.000 description 2
- DKIDEFUBRARXTE-UHFFFAOYSA-N 3-mercaptopropanoic acid Chemical compound OC(=O)CCS DKIDEFUBRARXTE-UHFFFAOYSA-N 0.000 description 2
- QZGXGDOMKFBDID-UHFFFAOYSA-N 4-ethenylpyrene Chemical compound C1=CC=C2C(C=C)=CC3=CC=CC4=CC=C1C2=C34 QZGXGDOMKFBDID-UHFFFAOYSA-N 0.000 description 2
- ATYUCXIJDKHOPX-UHFFFAOYSA-N 5-[4-[(9h-fluoren-9-ylmethoxycarbonylamino)methyl]-3,5-dimethoxyphenoxy]pentanoic acid Chemical compound COC1=CC(OCCCCC(O)=O)=CC(OC)=C1CNC(=O)OCC1C2=CC=CC=C2C2=CC=CC=C21 ATYUCXIJDKHOPX-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 2
- VVJKKWFAADXIJK-UHFFFAOYSA-N Allylamine Chemical compound NCC=C VVJKKWFAADXIJK-UHFFFAOYSA-N 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 2
- 239000004342 Benzoyl peroxide Substances 0.000 description 2
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 239000004971 Cross linker Substances 0.000 description 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 2
- 239000005977 Ethylene Substances 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- XXROGKLTLUQVRX-UHFFFAOYSA-N allyl alcohol Chemical compound OCC=C XXROGKLTLUQVRX-UHFFFAOYSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- 229960003328 benzoyl peroxide Drugs 0.000 description 2
- 235000019400 benzoyl peroxide Nutrition 0.000 description 2
- AOJOEFVRHOZDFN-UHFFFAOYSA-N benzyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC1=CC=CC=C1 AOJOEFVRHOZDFN-UHFFFAOYSA-N 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000001268 conjugating effect Effects 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- ZQMIGQNCOMNODD-UHFFFAOYSA-N diacetyl peroxide Chemical compound CC(=O)OOC(C)=O ZQMIGQNCOMNODD-UHFFFAOYSA-N 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 2
- 150000004820 halides Chemical class 0.000 description 2
- 238000000265 homogenisation Methods 0.000 description 2
- CBOIHMRHGLHBPB-UHFFFAOYSA-N hydroxymethyl Chemical compound O[CH2] CBOIHMRHGLHBPB-UHFFFAOYSA-N 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229920005615 natural polymer Polymers 0.000 description 2
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 2
- 150000001451 organic peroxides Chemical class 0.000 description 2
- 229940038597 peroxide anti-acne preparations for topical use Drugs 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- 230000000379 polymerizing effect Effects 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000001294 propane Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 238000013269 sustained drug release Methods 0.000 description 2
- 150000003573 thiols Chemical class 0.000 description 2
- AASBXERNXVFUEJ-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) propanoate Chemical compound CCC(=O)ON1C(=O)CCC1=O AASBXERNXVFUEJ-UHFFFAOYSA-N 0.000 description 1
- PSGCQDPCAWOCSH-UHFFFAOYSA-N (4,7,7-trimethyl-3-bicyclo[2.2.1]heptanyl) prop-2-enoate Chemical compound C1CC2(C)C(OC(=O)C=C)CC1C2(C)C PSGCQDPCAWOCSH-UHFFFAOYSA-N 0.000 description 1
- QWMJEUJXWVZSAG-UHFFFAOYSA-N (4-ethenylphenyl)boronic acid Chemical compound OB(O)C1=CC=C(C=C)C=C1 QWMJEUJXWVZSAG-UHFFFAOYSA-N 0.000 description 1
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- KOMNUTZXSVSERR-UHFFFAOYSA-N 1,3,5-tris(prop-2-enyl)-1,3,5-triazinane-2,4,6-trione Chemical compound C=CCN1C(=O)N(CC=C)C(=O)N(CC=C)C1=O KOMNUTZXSVSERR-UHFFFAOYSA-N 0.000 description 1
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 1
- VBVXQWDAICFGRI-UHFFFAOYSA-N 1-ethenyl-4-(2-phenylphenyl)benzene Chemical group C1=CC(C=C)=CC=C1C1=CC=CC=C1C1=CC=CC=C1 VBVXQWDAICFGRI-UHFFFAOYSA-N 0.000 description 1
- IMQFZQVZKBIPCQ-UHFFFAOYSA-N 2,2-bis(3-sulfanylpropanoyloxymethyl)butyl 3-sulfanylpropanoate Chemical compound SCCC(=O)OCC(CC)(COC(=O)CCS)COC(=O)CCS IMQFZQVZKBIPCQ-UHFFFAOYSA-N 0.000 description 1
- ZMZGFLUUZLELNE-UHFFFAOYSA-N 2,3,5-triiodobenzoic acid Chemical compound OC(=O)C1=CC(I)=CC(I)=C1I ZMZGFLUUZLELNE-UHFFFAOYSA-N 0.000 description 1
- OWPUOLBODXJOKH-UHFFFAOYSA-N 2,3-dihydroxypropyl prop-2-enoate Chemical compound OCC(O)COC(=O)C=C OWPUOLBODXJOKH-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- XMNIXWIUMCBBBL-UHFFFAOYSA-N 2-(2-phenylpropan-2-ylperoxy)propan-2-ylbenzene Chemical compound C=1C=CC=CC=1C(C)(C)OOC(C)(C)C1=CC=CC=C1 XMNIXWIUMCBBBL-UHFFFAOYSA-N 0.000 description 1
- LEJBBGNFPAFPKQ-UHFFFAOYSA-N 2-(2-prop-2-enoyloxyethoxy)ethyl prop-2-enoate Chemical compound C=CC(=O)OCCOCCOC(=O)C=C LEJBBGNFPAFPKQ-UHFFFAOYSA-N 0.000 description 1
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 description 1
- NDKDFTQNXLHCGO-UHFFFAOYSA-N 2-(9h-fluoren-9-ylmethoxycarbonylamino)acetic acid Chemical compound C1=CC=C2C(COC(=O)NCC(=O)O)C3=CC=CC=C3C2=C1 NDKDFTQNXLHCGO-UHFFFAOYSA-N 0.000 description 1
- ULIKDJVNUXNQHS-UHFFFAOYSA-N 2-Propene-1-thiol Chemical compound SCC=C ULIKDJVNUXNQHS-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- HAZWONBCJXKAMF-UHFFFAOYSA-N 2-[1-[1,3-bis[2-(oxiran-2-ylmethoxy)propoxy]propan-2-yloxy]propan-2-yloxymethyl]oxirane Chemical compound C1OC1COC(C)COCC(OCC(C)OCC1OC1)COCC(C)OCC1CO1 HAZWONBCJXKAMF-UHFFFAOYSA-N 0.000 description 1
- SBOXDRICSJHEBA-UHFFFAOYSA-N 2-[2-(2-methoxyethoxymethyl)-2-(2-prop-2-enoyloxyethoxymethyl)butoxy]ethyl prop-2-enoate Chemical compound C=CC(=O)OCCOCC(COCCOC)(CC)COCCOC(=O)C=C SBOXDRICSJHEBA-UHFFFAOYSA-N 0.000 description 1
- LJRSZGKUUZPHEB-UHFFFAOYSA-N 2-[2-(2-prop-2-enoyloxypropoxy)propoxy]propyl prop-2-enoate Chemical compound C=CC(=O)OC(C)COC(C)COC(C)COC(=O)C=C LJRSZGKUUZPHEB-UHFFFAOYSA-N 0.000 description 1
- HCZMHWVFVZAHCR-UHFFFAOYSA-N 2-[2-(2-sulfanylethoxy)ethoxy]ethanethiol Chemical compound SCCOCCOCCS HCZMHWVFVZAHCR-UHFFFAOYSA-N 0.000 description 1
- VUIWJRYTWUGOOF-UHFFFAOYSA-N 2-ethenoxyethanol Chemical compound OCCOC=C VUIWJRYTWUGOOF-UHFFFAOYSA-N 0.000 description 1
- JYBJXKVJBAHQNF-UHFFFAOYSA-N 2-ethenylanthracene Chemical compound C1=CC=CC2=CC3=CC(C=C)=CC=C3C=C21 JYBJXKVJBAHQNF-UHFFFAOYSA-N 0.000 description 1
- NFKLQCMEXOQZFO-UHFFFAOYSA-N 2-ethenyltetracene Chemical compound C1=CC=CC2=CC3=CC4=CC(C=C)=CC=C4C=C3C=C21 NFKLQCMEXOQZFO-UHFFFAOYSA-N 0.000 description 1
- LZDXRPVSAKWYDH-UHFFFAOYSA-N 2-ethyl-2-(prop-2-enoxymethyl)propane-1,3-diol Chemical compound CCC(CO)(CO)COCC=C LZDXRPVSAKWYDH-UHFFFAOYSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 1
- KIFPIAKBYOIOCS-UHFFFAOYSA-N 2-methyl-2-(trioxidanyl)propane Chemical compound CC(C)(C)OOO KIFPIAKBYOIOCS-UHFFFAOYSA-N 0.000 description 1
- RCEJCSULJQNRQQ-UHFFFAOYSA-N 2-methylbutanenitrile Chemical compound CCC(C)C#N RCEJCSULJQNRQQ-UHFFFAOYSA-N 0.000 description 1
- XLLXMBCBJGATSP-UHFFFAOYSA-N 2-phenylethenol Chemical compound OC=CC1=CC=CC=C1 XLLXMBCBJGATSP-UHFFFAOYSA-N 0.000 description 1
- KGIGUEBEKRSTEW-UHFFFAOYSA-N 2-vinylpyridine Chemical compound C=CC1=CC=CC=N1 KGIGUEBEKRSTEW-UHFFFAOYSA-N 0.000 description 1
- MECNWXGGNCJFQJ-UHFFFAOYSA-N 3-piperidin-1-ylpropane-1,2-diol Chemical compound OCC(O)CN1CCCCC1 MECNWXGGNCJFQJ-UHFFFAOYSA-N 0.000 description 1
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 1
- KFDVPJUYSDEJTH-UHFFFAOYSA-N 4-ethenylpyridine Chemical compound C=CC1=CC=NC=C1 KFDVPJUYSDEJTH-UHFFFAOYSA-N 0.000 description 1
- NDWUBGAGUCISDV-UHFFFAOYSA-N 4-hydroxybutyl prop-2-enoate Chemical compound OCCCCOC(=O)C=C NDWUBGAGUCISDV-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- OGOYZCQQQFAGRI-UHFFFAOYSA-N 9-ethenylanthracene Chemical compound C1=CC=C2C(C=C)=C(C=CC=C3)C3=CC2=C1 OGOYZCQQQFAGRI-UHFFFAOYSA-N 0.000 description 1
- KTPLMACSFXCPHL-UHFFFAOYSA-N 9-ethenylphenanthrene Chemical compound C1=CC=C2C(C=C)=CC3=CC=CC=C3C2=C1 KTPLMACSFXCPHL-UHFFFAOYSA-N 0.000 description 1
- 238000006596 Alder-ene reaction Methods 0.000 description 1
- 108090001008 Avidin Proteins 0.000 description 1
- 229910015900 BF3 Inorganic materials 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 102000016289 Cell Adhesion Molecules Human genes 0.000 description 1
- 108010067225 Cell Adhesion Molecules Proteins 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 102100026735 Coagulation factor VIII Human genes 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 238000005698 Diels-Alder reaction Methods 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 description 1
- YIVJZNGAASQVEM-UHFFFAOYSA-N Lauroyl peroxide Chemical compound CCCCCCCCCCCC(=O)OOC(=O)CCCCCCCCCCC YIVJZNGAASQVEM-UHFFFAOYSA-N 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 108091093037 Peptide nucleic acid Proteins 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- 229910001069 Ti alloy Inorganic materials 0.000 description 1
- 229910021627 Tin(IV) chloride Inorganic materials 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- DAKWPKUUDNSNPN-UHFFFAOYSA-N Trimethylolpropane triacrylate Chemical compound C=CC(=O)OCC(CC)(COC(=O)C=C)COC(=O)C=C DAKWPKUUDNSNPN-UHFFFAOYSA-N 0.000 description 1
- BAECOWNUKCLBPZ-HIUWNOOHSA-N Triolein Natural products O([C@H](OCC(=O)CCCCCCC/C=C\CCCCCCCC)COC(=O)CCCCCCC/C=C\CCCCCCCC)C(=O)CCCCCCC/C=C\CCCCCCCC BAECOWNUKCLBPZ-HIUWNOOHSA-N 0.000 description 1
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- JUDXBRVLWDGRBC-UHFFFAOYSA-N [2-(hydroxymethyl)-3-(2-methylprop-2-enoyloxy)-2-(2-methylprop-2-enoyloxymethyl)propyl] 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC(CO)(COC(=O)C(C)=C)COC(=O)C(C)=C JUDXBRVLWDGRBC-UHFFFAOYSA-N 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- IYPNRTQAOXLCQW-UHFFFAOYSA-N [4-(sulfanylmethyl)phenyl]methanethiol Chemical compound SCC1=CC=C(CS)C=C1 IYPNRTQAOXLCQW-UHFFFAOYSA-N 0.000 description 1
- 150000008062 acetophenones Chemical class 0.000 description 1
- HFBMWMNUJJDEQZ-UHFFFAOYSA-N acryloyl chloride Chemical compound ClC(=O)C=C HFBMWMNUJJDEQZ-UHFFFAOYSA-N 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 150000001412 amines Chemical group 0.000 description 1
- 238000010539 anionic addition polymerization reaction Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- 150000008366 benzophenones Chemical class 0.000 description 1
- GCTPMLUUWLLESL-UHFFFAOYSA-N benzyl prop-2-enoate Chemical compound C=CC(=O)OCC1=CC=CC=C1 GCTPMLUUWLLESL-UHFFFAOYSA-N 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- JQRRFDWXQOQICD-UHFFFAOYSA-N biphenylen-1-ylboronic acid Chemical compound C12=CC=CC=C2C2=C1C=CC=C2B(O)O JQRRFDWXQOQICD-UHFFFAOYSA-N 0.000 description 1
- HABAXTXIECRCKH-UHFFFAOYSA-N bis(prop-2-enyl) butanedioate Chemical compound C=CCOC(=O)CCC(=O)OCC=C HABAXTXIECRCKH-UHFFFAOYSA-N 0.000 description 1
- 125000005620 boronic acid group Chemical class 0.000 description 1
- PVEOYINWKBTPIZ-UHFFFAOYSA-N but-3-enoic acid Chemical compound OC(=O)CC=C PVEOYINWKBTPIZ-UHFFFAOYSA-N 0.000 description 1
- SMTOKHQOVJRXLK-UHFFFAOYSA-N butane-1,4-dithiol Chemical compound SCCCCS SMTOKHQOVJRXLK-UHFFFAOYSA-N 0.000 description 1
- CQEYYJKEWSMYFG-UHFFFAOYSA-N butyl acrylate Chemical compound CCCCOC(=O)C=C CQEYYJKEWSMYFG-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000010538 cationic polymerization reaction Methods 0.000 description 1
- 238000007156 chain growth polymerization reaction Methods 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000012650 click reaction Methods 0.000 description 1
- 238000004581 coalescence Methods 0.000 description 1
- 238000002648 combination therapy Methods 0.000 description 1
- 238000002591 computed tomography Methods 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 238000013267 controlled drug release Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 238000006352 cycloaddition reaction Methods 0.000 description 1
- 229940097362 cyclodextrins Drugs 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- KBLWLMPSVYBVDK-UHFFFAOYSA-N cyclohexyl prop-2-enoate Chemical compound C=CC(=O)OC1CCCCC1 KBLWLMPSVYBVDK-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000005034 decoration Methods 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- 229960002086 dextran Drugs 0.000 description 1
- LSXWFXONGKSEMY-UHFFFAOYSA-N di-tert-butyl peroxide Chemical compound CC(C)(C)OOC(C)(C)C LSXWFXONGKSEMY-UHFFFAOYSA-N 0.000 description 1
- 125000004386 diacrylate group Chemical group 0.000 description 1
- 238000002059 diagnostic imaging Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
- AFOSIXZFDONLBT-UHFFFAOYSA-N divinyl sulfone Chemical compound C=CS(=O)(=O)C=C AFOSIXZFDONLBT-UHFFFAOYSA-N 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000001493 electron microscopy Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- YCUBDDIKWLELPD-UHFFFAOYSA-N ethenyl 2,2-dimethylpropanoate Chemical compound CC(C)(C)C(=O)OC=C YCUBDDIKWLELPD-UHFFFAOYSA-N 0.000 description 1
- ZLHVSEPPILCZHH-UHFFFAOYSA-N ethenyl 4-tert-butylbenzoate Chemical compound CC(C)(C)C1=CC=C(C(=O)OC=C)C=C1 ZLHVSEPPILCZHH-UHFFFAOYSA-N 0.000 description 1
- CMDXMIHZUJPRHG-UHFFFAOYSA-N ethenyl decanoate Chemical compound CCCCCCCCCC(=O)OC=C CMDXMIHZUJPRHG-UHFFFAOYSA-N 0.000 description 1
- UIWXSTHGICQLQT-UHFFFAOYSA-N ethenyl propanoate Chemical compound CCC(=O)OC=C UIWXSTHGICQLQT-UHFFFAOYSA-N 0.000 description 1
- 238000012632 fluorescent imaging Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 238000007306 functionalization reaction Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 229940014259 gelatin Drugs 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 125000003055 glycidyl group Chemical group C(C1CO1)* 0.000 description 1
- JSRUFBZERGYUAT-UHFFFAOYSA-N hexadecane-1,16-dithiol Chemical compound SCCCCCCCCCCCCCCCCS JSRUFBZERGYUAT-UHFFFAOYSA-N 0.000 description 1
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 1
- 239000012216 imaging agent Substances 0.000 description 1
- 239000000568 immunological adjuvant Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 238000010550 living polymerization reaction Methods 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 238000002595 magnetic resonance imaging Methods 0.000 description 1
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 238000012703 microemulsion polymerization Methods 0.000 description 1
- JESXATFQYMPTNL-UHFFFAOYSA-N mono-hydroxyphenyl-ethylene Natural products OC1=CC=CC=C1C=C JESXATFQYMPTNL-UHFFFAOYSA-N 0.000 description 1
- GYVGXEWAOAAJEU-UHFFFAOYSA-N n,n,4-trimethylaniline Chemical compound CN(C)C1=CC=C(C)C=C1 GYVGXEWAOAAJEU-UHFFFAOYSA-N 0.000 description 1
- CMWYAOXYQATXSI-UHFFFAOYSA-N n,n-dimethylformamide;piperidine Chemical compound CN(C)C=O.C1CCNCC1 CMWYAOXYQATXSI-UHFFFAOYSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000002414 normal-phase solid-phase extraction Methods 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- RPQRDASANLAFCM-UHFFFAOYSA-N oxiran-2-ylmethyl prop-2-enoate Chemical compound C=CC(=O)OCC1CO1 RPQRDASANLAFCM-UHFFFAOYSA-N 0.000 description 1
- HDBWAWNLGGMZRQ-UHFFFAOYSA-N p-Vinylbiphenyl Chemical group C1=CC(C=C)=CC=C1C1=CC=CC=C1 HDBWAWNLGGMZRQ-UHFFFAOYSA-N 0.000 description 1
- HVAMZGADVCBITI-UHFFFAOYSA-M pent-4-enoate Chemical compound [O-]C(=O)CCC=C HVAMZGADVCBITI-UHFFFAOYSA-M 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- ULDDEWDFUNBUCM-UHFFFAOYSA-N pentyl prop-2-enoate Chemical compound CCCCCOC(=O)C=C ULDDEWDFUNBUCM-UHFFFAOYSA-N 0.000 description 1
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- YFMFSCRSAWIWOP-UHFFFAOYSA-N phenyl(trityl)diazene Chemical compound C1=CC=CC=C1N=NC(C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 YFMFSCRSAWIWOP-UHFFFAOYSA-N 0.000 description 1
- 238000002600 positron emission tomography Methods 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- PNXMTCDJUBJHQJ-UHFFFAOYSA-N propyl prop-2-enoate Chemical compound CCCOC(=O)C=C PNXMTCDJUBJHQJ-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000009919 sequestration Effects 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- 238000002603 single-photon emission computed tomography Methods 0.000 description 1
- 229940126586 small molecule drug Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000002594 sorbent Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 229940032147 starch Drugs 0.000 description 1
- 238000007155 step growth polymerization reaction Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- GJBRNHKUVLOCEB-UHFFFAOYSA-N tert-butyl benzenecarboperoxoate Chemical compound CC(C)(C)OOC(=O)C1=CC=CC=C1 GJBRNHKUVLOCEB-UHFFFAOYSA-N 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- HPGGPRDJHPYFRM-UHFFFAOYSA-J tin(iv) chloride Chemical compound Cl[Sn](Cl)(Cl)Cl HPGGPRDJHPYFRM-UHFFFAOYSA-J 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 1
- 229940117972 triolein Drugs 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- ZTWTYVWXUKTLCP-UHFFFAOYSA-N vinylphosphonic acid Chemical compound OP(O)(=O)C=C ZTWTYVWXUKTLCP-UHFFFAOYSA-N 0.000 description 1
- NLVXSWCKKBEXTG-UHFFFAOYSA-N vinylsulfonic acid Chemical compound OS(=O)(=O)C=C NLVXSWCKKBEXTG-UHFFFAOYSA-N 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F2/00—Processes of polymerisation
- C08F2/12—Polymerisation in non-solvents
- C08F2/16—Aqueous medium
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F128/00—Homopolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a bond to sulfur or by a heterocyclic ring containing sulfur
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/10—Esters
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/62—Monocarboxylic acids having ten or more carbon atoms; Derivatives thereof
- C08F220/68—Esters
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02C—CAPTURE, STORAGE, SEQUESTRATION OR DISPOSAL OF GREENHOUSE GASES [GHG]
- Y02C20/00—Capture or disposal of greenhouse gases
- Y02C20/40—Capture or disposal of greenhouse gases of CO2
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
Abstract
A polymer particle prepared from a nucleated composition, formed spontaneously and instantaneously in absence of surfactant, stabilizer, or dispersant and without extended agitation, and comprising a monomer of formula (I), and a process for preparation of said polymer particle are provided:(I)wherein;(a) X is -CH2-, -O-CH2-CH2-, -O-CH2-CH(CH3)-, or -O-CH(CH3)-CH2-; (b) Y is -O-C(O)-CH=CH2, -O-C(O)-C(CH3)=CH2, -NH-C(O)-CH=CH2, -NH-C(O)-C(CH3)=CH2,-O-CH=CH2, -O-CH2-CH=CH2, -CH=CH2,-CH2-CH=CH2, -O-C(O)-CH2-CH2-SH, -NH-C(O)-CH2-CH2-SH, or SH;(c) Z is -CH2-XP-Y, a hydrogen, a functional group, an alkyl group, or a functionalized alkyl group; and(d) each of 1, m, n, and p is independently a number in the range 0-25.
Description
A polymer is a macromolecule built up of many small building blocks, also referred toas monomers. The polymers are often divided into synthetic ones and natural ones. Thesynthetic polymers are manmade. The natural polymers are the polymers found in nature butcan also be synthesized and/or modified in laboratories and industries. The composition of apolymer is deterrnined by the monomers used for its preparation. The monomers will bringcertain Characteristics to the polymer. For example, a functional monomer will provide thepolymer with functional groups and a cross-linking monomer will provide a cross-linkedpolymer network. After polymerization, the polymer may be processed further by a range ofpost-polymerization procedures in order to prepare it for its final application. For example,functionalization will provide new functional groups, coupling with molecules of various sizesand types will provide new characteristics and properties, further cross-linking or attachmentto surfaces will increase the stability, and derivatization with biocompatible compounds willincrease the biocompatibility of the polymer.
Polymers can be prepared in different size and shape. Polymer particles are particularlyinteresting since they are used in a wide range of applications in many sectors in the society[Gokmen and Prez, Progress in Polymer Science 37 (2012) 365-405]. In laboratory andchemical industry settings, polymer particles are used as stationary phases in various small andlarge-scale separations and purif1cations (e.g., in liquid chromatography and solid-phaseextraction), as supports (solid phases) in solid-phase synthesis, as supports for immobilizationof macromolecules and cells, as catalysts, etc. Emerging applications in medicine include theiruse as carriers in drug delivery and tissue engineering, as immunologic adjuvants in vaccines,and as recognition elements in assay and sensor applications. In the environmental and energyf1elds, polymer particles are useful as sorption media for purif1cation of water, for hydrogenstorage, and for carbon capture/sequestration. Another application area is in printing andadditive manufacturing for the production of 2D- and 3D-structures and objects. Polymer particles are also used in a wide range of consumer products such as cosmetics, detergents, and toothpaste. Hence, there is a large need of polymer particles as Well as efficient and sustainablemethods for their preparation.
Polymer particles of various sizes and shapes can be prepared by a range of methods,for example, by mechanical disintegration of monolithic polymers, by dispersionpolymerization, by precipitation polymerization, by suspension polymerization, or by emulsionpolymerization. Mechanical disintegration of monolithic polymers into particles is a tediousprocedure and typically provides irregularly shaped particles; fractionation is required toprovide the desired size range, often resulting in low yields. While both dispersionpolymerization and precipitation polymerization involve precipitation of the polymer duringthe polymerization, the former method typically provides micro-sized particles Whileprecipitation polymerization provides particles in the sub-micron size range. In both methods,the particles precipitate as they polymerize from a homogenous highly diluted solution ofmonomers dissolved in an organic solvent. In dispersion polymerization, a colloidal stabilizeris present in the solution. Key to both dispersion polymerization and precipitationpolymerization is that the solvent should be a good solvent for the monomers but a poor solventfor the polymer particles to promote precipitation during the polymerization. In suspensionpolymerization, Water-insoluble monomers are suspended in a continuous Water phase byvigorous mixing. Stabilizers, for example, polymers or detergents, are used to stabilize andprevent coalescence of the droplets formed during the agitation. Addition of a Water-immiscibleporogenic solvent to the suspended phase influences on the size and porosity of the particles.Polymerization is typically carried out by free-radical polymerization using an initiatordissolved in the suspended phase. Mixing is continued throughout the full polymerization timeperiod. A Wide range of particle sizes, from sub-micrometer to several millimeters in diameter,can be produced by suspension polymerization. In emulsion polymerization, Water-insolublemonomers and surfactants are dispersed in a continuous Water phase by vigorous stirring,resulting in the formation of monomer-containing small micelles and larger droplets ofmonomers. Polymerization of the monomers in the micelles, using a Water-soluble initiator,provides polymer particles, Which continuously grow by diffusion of monomers from the largermonomer droplets to the micelles until the monomers are depleted in the droplets. Typical sizesof the resulting particles are around 100 nm. In mini-emulsion polymerization, a co-stabilizeris used in addition to the surfactant and high-sheer mixing by, for example, ultrasound isapplied. Polymerization using a Water-soluble initiator provides polymer particles in the sizerange 50-500 nm. In micro-emulsion polymerization, a high concentration of surfactant is used to produce a therrnodynamically stable micro-emulsion of monomer-filled micelles, Which are polymerized after addition of a Water-soluble initiator. The typical particles size of the resultingparticles is in the range 10-50 nm.
Overall, current methods for producing polymer particles are rather complex, labor-intensive, and non-sustainable; improved methods are clearly needed. The present inventionaddresses these needs by providing environmentally friendly, low energy-consuming, and sustainable methods for the production of polymer particles.
SUMMARY OF THE INVENTION The invention provides synthetic polymer particles suitable for a range of applications.In one embodiment, a polymer particle prepared from a nucleated composition, formedspontaneously and instantaneously in absence of surfactant, stabilizer, or dispersant and Without extended agitation, and comprising a monomer of the following forrnula: (1).i eeeeee eeeeeeeee eeeeeeee frå, eeeeeeeeeeee “fl X» MW*Wherein; (a) X is -CH2-, -O-CHz-CHr, -O-CH2~CH(CH3)-, or -O-CH(CH3)-CH2-; (b) Y is -O-C(O)-CH=CH2, -O-C(O)-C(CH3)=CH2, -NH-C(O)-CH=CHz,-NH-C(O)-C(CH3)=CHz, -O-CH=CH2, -O-CHz-CH=CHz, -CH=CHz,-CHz-CH=CH2, -O-C(O)-CHz-CHz-SH, -NH-C(O)-CHz-CH2~SH, or SH; (c) Z is -CHg-Xp-Y, a hydrogen, a functional group, an alkyl group, or a functionalizedalkyl group; and (d) each of l, m, n, and p is independently a number in the range 0-In another embodiment the polymer particle is further comprised of additional co-polymerized monomer(s).
In another embodiment the invention provides a process for preparing said polymerparticle comprising the steps: (a) dissolving the monomer(s) in a Water-miscible solvent, forrning a solution comprising said monomer(s); (b) interfacing said solution and a Water phase, in absence of surfactant, stabilizer, ordispersant and Without extended agitation, to form a mixture in Which spontaneousand instantaneous formation of nucleated droplets comprising said monomer takesplace; and (c) polymerizing said monomer(s) by a polymerization reaction.
The novel process of the invention is based on a concept that is different thanconventional and prior-art methods for the production of polymer particles. The inventionprovides, spontaneously and instantaneously, droplets of monomers through a simple,environmentally friendly, and energy-efficient procedure. The droplets nucleate When apreferred proportion of a solution, comprising monomers dissolved in a Water-miscible solvent,is interfaced With a Water phase. Only a brief initial mixing is required to interface the tWoliquids for the formation of the droplets; no extended mechanical agitation is required and nosurfactants, stabilizers, or dispersants are needed. A non-toxic harrnless solvent such as ethanolcan be used as the Water-miscible solvent, making the procedure environmentally friendly byobviating the use of harrnful solvents. The droplets are easily transforrned into solid particlesby polymerization. The polymer particles of the invention may be used directly for the intendedapplication or may be further processed before their final use. The particles are useful in allapplications Where polymer particles are needed. The particles of the invention are particularlysuitable for use as supports in solid-phase synthesis, as drug carriers in targeted drug deliveryand sustained drug release, as contrast agents or markers in medical imaging, and as sorbents in separations and purifications.
BRIEF DESCRIPTION OF THE DRAWINGS Figure l. (a) Right triangle phase diagram of the ternary system PETRA-ethanol-Waterbefore polymerization. The region providing nucleated droplets, appropriate for polymerizationto particles, is located below the dotted line. (b) Right triangle phase diagram afterpolymerization.
Figure 2. Influence of interfacing method on the particle size distribution ofpoly(PETRA). Interfacing Was carried out by (a) manual shaking (20 inversions); (b) stirringusing an overhead stirrer equipped With a radial flow impeller (700 rpm, 3 min); (c) homogenization using a homogenizer equipped With a dispersing element (8 000 rpm, l min); and (d) homogenization using an ultrasonic homogenizer equipped With an ultrasonic probe(6 >< 10 s, 20 W). DLS analysis (intensity based, n=30) Was carried out on particles dissolvedin Water.
Figure 3. Influence of polymerization conditions on the particle size distribution ofpo1y(PETRA). Polymerization Was carried out by subjecting the samples to (a) heat (60 °C for6 h); or (b) UV light (350 nm for 2 h). DLS analysis (intensity based, n=l0) Was carried out onparticles dissolved in Water.
Figure 4. Derivatization of the polymer particle With (a) linkers to provide a solid-phasesynthesis support; (b) drugs to provide a drug-carrier suitable for sustained and/or controlleddrug release; (c) affmity ligands to provide a ligand-particle conjugate; (d) imaging probes toprovide a particle-based contrast agent; and (e) PEG chains to increase the biocompatibility ofthe polymer particle. The figure is schematic and although only one conjugated molecule isdraWn in each example, it should be understood that a multitude of molecules can be conjugatedto each particle.
Figure 5. Schematic draWing showing cross-sections of polymer particle-based drugcarriers prepared by (a) conjugating the drug to the particle; (b) adsorbing the drug to the surfaceof the particle; and (c) entrapping the drug in the polymer network.
DETAILED DESCRIPTION Several embodiments of the present invention are described in more detail below, Withreference to the accompanying draWings in order for those skilled in the art to be able to carryout the invention. The invention may, hoWever, be embodied in many different forms andshould not be construed as limited to the embodiments set forth herein. Furthermore, theterrninology used in the detailed description of the particular embodiments is not intended tobe limiting of the invention.
The invention provides in one embodiment polymer particles of Well-definedcompositions and size distributions. The size distribution is adjusted by adjusting theparameters of the preparation process. Typically, the polymer particles are in the size range 1-5000 nm. More typically, the polymer particles are in the size range 5-1500 nm. Most typically,the polymer particles are in the size range 10-1000 nm. The polymer particles are suitable fora range of applications, either applied directly as provided by the invention”s preparation process or after further post-polymerization processing.
The polynier particles of the invention are coniposed of polynier networks, formed bypolynierization of n1onon1ers, used as polynier building blocks. The group of n1onon1ers usedin the inVention can be divided into cross-linking n1onon1ers and non-cross-linking n1onon1ers.In one en1bodin1ent of the inVention, the polynier particles are con1prised of a polynierized cross-linking n1onon1er of the following forrnula (1): (1) ............... ..“...~....... är'z a: w: v Mwz-:n mms* Wherein; (a) X is -CH2-, -O-CHz-CHr, -O-CH2~CH(CH3)-, or -O-CH(CH3)-CH2-; (b) Y is -O-C(O)-CH=CH2, -O-C(O)-C(CH3)=CHz, -NH-C(O)-CH=CHz,-NH-C(O)-C(CH3)=CHz, -O-CH=CH2, -O-CHz-CH=CH2, -CH=CHz,-CHz-CH=CH2, -O-C(O)-CHz-CHz-SH, -NH-C(O)-CH2-CH2~SH, or SH; (c) Z is -CHg-Xp-Y, a hydrogen, a functional group, an alkyl group, or a functionalizedalkyl group; and (d) each of l, ni, n, and p is independently a nun1ber in the range 0-Exaniples of other cross-linking n1onon1ers that can be applied as a polynier buildingblock in the inVention include, but are not lin1ited to, divinylbenzene [H2C=CH-C6H4-CH=CH2], ether [C9H16O5],[H2C=C(CH3)CO2CH2CH[OR(H)]CH2OH(R); R = H or COC(CH3)=CH2], diVinyl sulfone[(HzC=CH)2SO2], [HzC=CH-C(O)-O-CH=CHz],[H2C=C(CH3)-C(O)-O-CH=CH2], ethylene glycol diacrylate [H2C=CH-C(O)-O-CH2-CHz-O-C(O)-CH=CH2], ethylene glycol diniethacrylate [H2C=C(CH3)-C(O)-O-CH2-CH2-O-C(O)-C(CH3)=CH2], di(ethylene glycol) diniethacrylate [[H2C=C(CH3)-C(O)-O-CH2CH2]2O], di(ethylene glycol) diacrylate [[H2C=CH-C(O)-O-CH2-CH2]20], l,4-butanediol diacrylate [H2C=CH-C(O)-O-(CHz)4-O-C(O)-CH=CH2), l,4-butanedioldiniethacrylate [H2C=C(CH3)-C(O)-O-(CH2)4~O-C(O)-C(CH3)=CHz), glycerol propoxylatetriglycidyl ether, tri(propylene glycol)diacrylate [H2C=CH-C(O)-(O(CH2)3)3-O-C(O)-CH=CH2], tri(propylene glycol)din1ethacrylate [HgC=C(CHg)-C(O)-(O(CH2)3)3-O-C(O)-C(CH3)=CH2], poly(ethylene glycol-400)-diacrylate [H2C=CH-C(O)-(OCHzCHz)9~O-C(O)- glycerol diglycidyl glycerol diniethacrylate Vinyl acrylate Vinyl niethacrylate CH=CH2], poly(ethylene glyco1-400)-dirneth-acry1ate [H2C=C(CH3)-C(O)-(OCH2CH2)9-O-C(O)-C(CH3)=CH2], N,N”-methylenediacrylamide [H2C=CH-C(O)-NH-CH2-NH-C(O)-CH=CH2], N,N”-methylenedimethacrylarnide [H2C=C(CH3)-C(O)-NH-CH2-NH-C(O)-C(CH3)=CHz], [H2C=CH-C(O)-NH-C6H4-NH-C(O)-CH=CH2], N,N°-phenylenedimethacrylamide [HgC=C(CHg)-C(O)-NH-C6H4-NH-C(O)-C(CH3)=CH2], 3,5-bis(acryloylamido)benzoic acid [H2C=CH-C(O)-NH-C6H3(COzH)-NH-C(O)-CH=CH2], 3,5-bis(rnethacryloylamido)benzoic acid [H2C=C(CHs)~C(O)-NH-C6H3(CO2H)-NH-C(O)-C(CH3)=CH2], N,O-bisacryloyl-L-phenylalanino1 [H2C=CH-C(O)-NH-CH(CH2-C6Hs)~CH2-O-C(O)-CH=CH2], N,O-bismethacryloyl-L-phenylalaninol[H2C=C(CH3)-C(O)-NH-CH(CHz-C6Hs)~CHz-O-C(O)-C(CH3)=CHz],[H2C=CH-C(O)-O-CH=CH2], Vinyl rnethacrylate [H2C=C(CH3)-C(O)-O-CH=CH2], diallylsuccinate [(CH2CO2CH2CH=CH2)2], [(H2C=CH-O-CH2)3C(C2H5)], 2,4,6-tria11y10xy-1,3,5-triazine [C12H15N3O3], 1,3,5-tria11y1-1,3,5-triazine-2,4,6(1H,3H,5H)-tri0ne, tris[2-(acryloyloxy)ethyl]-isocyanuratq difirirnethylol-propane)[((H2C=CH-C(O)-O-CHz)zC(C2Hs)~CH2)2O], di(trirnethylolpropane)tetramethacrylate [((H2C=C(CH3)-C(O)-O-CH2)zC(C2Hs)~CH2)zO],tetraacrylate [C(CH2-O-C(O)-CH=CHz)4], pentaerythritol tetramethacrylate [C(CH2-O-C(O)-C(CH3)=CH2)4], pentaerythritol triacrylate (PETRA) [HO-CH2-C(CH2-O-C(O)-CH=CH2)3], pentaerythritol trimethacrylate [HO-CH2-C(CH2-O-C(O)-C(CH3)=CH2)3],trimethylolpropane triacrylate [CHg-CHg-C(CH2-O-C(O)-CH=CH2)3], trimethylolpropanetrimethacrylate (TRIM) [CH3-CH2-C(CH2-O-C(O)-C(CH3)=CH2)3], trimethylolpropanebenzoate [(H2C=CH-C(O)-O-CH2)2C(C2H5)-CH2-O-C(O)-C6H5],trimethylolpropane benzoate dirnethacrylate [(H2C=C(CH3)-C(O)-O-CH2)2C(C2H5)-CH2-O-C(O)-C6H5], trimethylolpropane allyl ether [H2C=CH-CH2-O-CH2-C(C2H5)(CH2OH)2,trimethylolpropane diallyl ether [C2H5C(CH2OCH2CH=CH2)2CH2OH], trimethylolpropaneethoxylate ( 1 EO/ OH) [H2C=CH-C (O)-O-CHz-CHz-O-CHz)zC(CzHs)~CHz-O-CHz-CHz-O-CH;], pentaerythritol ethoxylate (3/4 EO/OH)tetraacrylate [C[CH2(OCH2CHz)nO-C(O)-CH=CH2]4, pentaerythritol ethoxylate (3/4 EO/OH)tetramethacrylate [C[CH2(OCHzCHz)nO-C(O)-C(CH3)=CH2]4, pentaerythritol propoxylate(5/4 PO/OH)tetraacry1ate [C[CHg[OCH2CH(CH3)]11O-CH=CH2]4, pentaerythritol propoxylate(5/4 PO/OH) tetramethacrylate [C[CHg[OCHgCH(CHg)]nO-C(CH3)=CH2]4, pentaerythritolethoxylate (15/4 EO/OH) tetraacrylate [C[CH2(OCH2CHz)nO-C(O)-CH=CH2]4,pentaerythritol ethoxylate (15/4 EO/OH) tetramethacrylate [C[CH2(OCH2CH2)HO-C(O)-C(CH3)=CH2]4, trimethylolpropane ethoxylate (lEO/OH) rnethyl ether dirnethacrylate N,N°-phenylenediacrylamide Vinyl acrylate trimethylolpropane trivinyl ether tetraacrylatepentaerythritol diacrylate rnethyl ether diacrylate [H2C=C(CH3)-C(O)-O-CHz-CHz-O-CHz)zC(CzHs)~CHz-O-CHz-CHz-O-CHs],trimethylolpropane ethoxylate (1/3 EO/OH) triacrylate [(H2C=CH-C(O)-O-(CH2-CH2-O)nCH2)3C-C2Hs], ethoxylate (1/3 EO/OH)[(H2C=C(CH3)-C(O)-O-(CH2-CH2-O)11CH2)3C-C2H5], trimethylolpropane ethoxylate (7/3EO/OH) triacrylate [(H2C=CH-C(O)-O-(CH2-CH2-O)HCH2)3C-CzHs], trimethylolpropaneethoxylate (7/3 EO/OH) trimethacrylate [(H2C=C(CH3)-C(O)-O-(CHz-CHz-O)nCHz)sC-C2H5], trimethylolpropane ethoxylate (14/3 EO/OH) triacrylate [(H2C=CH-C(O)-O-(CH2-CH2-O)nCH2)3C-C2H5], trimethylolpropane ethoxylate (14/3 EO/OH) trimethacrylate[(H2C=C(CH3)-C(O)-O-(CH2-CHz-O)HCH2)3C-CzHs],(1/PO/OH) triacrylate [(H2C=CH-C(O)-O-(C3H6O)n-CHz)3C-CzHs], trimethylolpropanepropoxylate (1/PO/OH) trimethacrylate [(H2C=C(CH3)-C(O)-O-(C3H6O)n-CH2)3C-C2H5],trimethylolpropane propoxylate (2PO/OH) triacrylate [(H2C=CH-C(O)-O-(C3H6O)n-CH2)3C-C2H5], trimethylolpropane propoxylate (2PO/OH) trimethacrylate [(H2C=C(CH3)-C(O)-O-(C3H6O)n-CH2)3C-C2H5], glycerol propoxylate (lPO/OH) triacrylate [[H2C=CH-C(O)-O-[CH(CH3)~CH2-O]1CH2][H2C=CH-C(O)-O-[CH(CH3)~CHz-O]m][H2C=CH-C(O)-O-[CH(CHs)~CHz-O]nCHz][-CH],[CHFCH-C(O)-O-(C3H6O)X-(CH2CH2O)y-CH[CHz-(OCHzCH2)y-(OC3H6)X-O-C(O)-CH=CH2]2], triolein [CH3-(CH2)7-CH=CH-(CH2)7-C(O)-O-CH(CH2-O-C(O)-(CH2)7-CH=CH-(CH2)7-CH3)2], trimethylolpropane triglycidyl ether [C15H26O6], 2,2-bis[4-(2-hydroxy-S-methacryloyloxypropoxy)phenyl]-propane, bisphenol-Adirnethacrylate, pentaerythritol tetrakis(3-mercaptopropionate) [(HS-CH2-CH2-C(O)-O-CH2)4C], trimethylolpropane tris(3-mercaptopropionate) [(HS-CH2-CH2-C(O)-O-CH2)3C-C2H5], 2-hydroxyrnethyl-2-rnethyl-1ß-propanediol tris-(S-mercaptopropionate) [(HS-CH2-CH2-C(O)-O-CH2)3C-CH3], 2,2-bis(su1fany1rnethy1)-1ß-propanedithiol [(HS-CH2)4C],glycol di-S-mercaptopropionate, p01y(ethy1ene glycol) dithiol [HS-CHg-CHg-(O-CHQ-CH2)n-SH], 1,3,4-thiadiaz01e-2,5-dithioL [C2H2N2S3], toluene-ßA-dithiol [CH3C6H3(SH)2],benzene-lA-dithiol, benzene-IJ-dithiol, LS-benzenedithiol [C6H4(SH)2], bipheny1-4,4'-dithiol [HS-C6H4-C6H4-SH], p-terpheny1-4,4”-dithio1 [HS-C6H4-C6H4-C6H4-SHLhexa(ethylene glycol) dithiol [HS-(CHg-CHg-O)5-CH2-CH2-SH], tetra(ethy1ene glycol)dithiol [HS-(CHg-CHg-Oß-CHg-CHg-SH], 2,2'-(ethylenedioxy)diethanethiol [HS-CHg-CHg-O-CHz-CHæO-CHz-CHrSH], 1,4-benzenedimethane-thiol [C6H4(CH2SH)2], 1,16-hexadecanedithiol [HS-(CH2)16-SH], dithiothreitol [HS-CHg-CH(OH)-CH(OH)-CH2-SH],2-rnercaptoethyl ether [O(CH2CH2SH)2], LS-propanedithiol [HS-(CH2)3-SH], 1,4-butanedithiol [HS-(CH2)4-SH], LS-pentanedithiol [HS-(CH2)5-SH], Ló-hexane dithiol [HS- trimethylolpropane trimethacrylate trimethylolpropane propoxylate glycerol ethoxylate-co-propoxylate triacrylate ethoxylated (CH2)6-SH], 4arrn-PEG-SH [C(CH2-O-(CH2CH2O)11CH2CH2SH)4], Sarrn-PEG-SH, andanalogs and derivatives of these.
Exaniples of non-crosslinking n1onon1ers that can be used in the invention include, butare not lin1ited to, acid-containing n1onon1ers such as acrylic acid, niethacrylic acid (MAA),trifluoroniethacrylic acid, itaconic acid, Vinylacetic acid, 4-Vinylbenzoic acid (4-VBA), 4-Vinylphenylboronic acid, Vinylsulfonic acid, and Vinylphosphonic acid; ester-containingn1onon1ers such as Vinyl acetate, Vinyl propionate, Vinyl pivalate, allyl acetate, niethyl acrylate,n1ethyl niethacrylate, ethyl acrylate, ethyl niethacrylate, propyl acrylate, propyl niethacrylate,butyl acrylate, butyl niethacrylate, pentyl acrylate, pentyl niethacrylate, cyclohexyl acrylate,cyclohexyl niethacrylate, benzyl acrylate, benzyl niethacrylate, isobornyl acrylate, isobornylniethacrylate, hydroxybutyl acrylate, hydroxybutyl niethacrylate, Vinyl decanoate, Vinyl 4-tert-butylbenzoate, glycidyl acrylate, and glycidyl niethacrylate; aniide-containing n1onon1ers suchas acrylaniide, niethacrylaniide, and N-Vinylacetaniide; aniino-containing n1onon1ers such asallyl an1ine, 2-an1inoethyl niethacrylate, 2-(diethylan1ino)ethyl niethacrylate,(Vinylbenzyl)trin1ethylan1n1oniun1 chloride, and 4-an1inostyrene; heteroaron1atic n1onon1erssuch as l-Vinyliniidazole, 4-Vinylpyridine, 2-Vinylpyridine, l-Vinyl-2-pyrrolidinone, N-Vinylcaprolactani, and N-Vinylphtaliniide; hydroxyl-containing n1onon1ers such as 4-alpha-Vinylbenzyl alcohol, 2-hydroxyethyl acrylate, hydroxystyrene, 2-hydroxyethyl niethacrylate (HEMA), S-hydroxypropyl acrylate, S-hydroxypropyl niethacrylate, 4- hydroxypropyl acrylate, 4-hydroxypropyl niethacrylate, S-hydroxypentyl acrylate, 5-hydroxypentyl niethacrylate, 2,3-dihydroxypropyl acrylate, 2,3-dihydroxypropyl niethacrylate,N-hydroxyniethylacrylaniide, N-hydroxyniethylniethacrylaniide, allyl alcohol, hydroxyethylVinyl ether, and allyl-2-hydroxy-2-phenyl ether; Vinyl acid halides such as acryloyl chloride,niethacryloyl chloride; halide-containing n1onon1ers such as Vinyl broniide and Vinyl chloride;thiol-containing n1onon1ers such as 2-propene-l-thiol; silane-containing n1onon1ers such asVinyltriniethylsilane, Vinyltriniethoxysilane, and 3-glycidoxypropyl-triniethoxysilane;aron1atic n1onon1ers such as styrene, 2-Vinyl anthracene, 9-Vinyl anthracene, l-Vinylnaphtalene,2-Vinylnaphtalene, l-Vinylphenanthrene, 9-Vinylphenanthrene, 4-Vinylbiphenyl, 4-Vinyl-o-terphenyl, 4-Vinylpyrene, 5-Vinylpyrene, 2-Vinyltetracene; and analogs and deriVatiVes of these.
In another enibodinient, the invention provides a process for preparing said polynierparticles coniprising the steps: (a) dissolving the n1onon1er(s) in a Water-niiscible solVent, forrning a solution coniprising said n1onon1er(s); (b) interfacing said solution and a Water phase to form a mixture in Which spontaneousand instantaneous formation of nucleated droplets comprising said monomer(s)takes place; and (c) polymerizing said monomer(s).
The process of the invention is particularly adVantageous since it is energy-efficient andenvironmentally friendly. The first step of the process is the preparation of a solutioncomprising the monomer(s) dissolved in a Water-miscible solvent. The resulting solution ishereafter referred to as the solution. Examples of suitable solVents for the preparation of thesolution include, but are not limited to, Water-miscible alcohols, acetonitrile, N,N-dimethylforrnamide (also named DMF), dimethyl sulfoxide (also named DMSO), acetone,acetic acid, acetaldehyde, hexamethylphosphoric triamide (also named HMPT),dimethoxyethane (also named glyme, monoglyme, dimethyl glycol, ethylene glycol dimethylether, dimethyl cellosolve, and DME), l,4-dioxane, N-methyl-2-pyrrolidone (also namedNMP), pyridine, tetrahydrofuran (also named THF), or combinations thereof. Examples ofalcohols include, but are not limited to, methanol, ethanol, l,2-ethanediol (also named ethyleneglycol), l-propanol, 2-propanol, 1,2-propanediol (also named propylene glycol), 1,3-propanediol, l-butanol, 2-butanol, l,2-butanediol, l,3-butanediol, l,4-butanediol, l-pentanol,2-pentanol, 3-pentanol, 1,2-pentanediol, l,3-pentanediol, 2,3-pentanediol, 2,4-pentanediol, l,4-pentanediol, l,5-pentanediol, glycerol (also named glycerine), erythritol (also named butane-l,2,3,4-tetrol), pentaerythritol (also named 2,2-bis(hydroxymethyl)propane-l,3-diol), furfurylalcohol, diethylene glycol (also named DEG), triethylene glycol (also named triglycol, TEG,and TREG), tetraethylene glycol, and pentaethylene glycol.
The next step of the process comprises interfacing the solution With Water by simplyadding the solution to Water or by, in addition, including a brief mixing/blending procedure,thereby forrning a mixture of monomer(s), Water-miscible solvent, and Water. In some cases,the momentum of the solution being added to the Water phase is enough to cause sufficientturbulence to mix/blend the tWo liquids. Upon mixing/blending, the Water-miscible solVentpartitions into the Water phase and nucleation (droplet forrnation) of the monomer(s) occurs.Key to successful nucleation is to provide preferred fractions of the three (or more) componentsin the mixture. The preferred fractions are estimated from an experimentally deterrnined phasediagram. As an example, a temary phase diagram of pentaerythritol triacrylate (PETRA), ethanol, and Water has been acquired and is provided in the format of a right triangle phase diagram in Figure la. Within the nucleation region, located below the dotted line in Figure la, nucleation occurs spontaneously and instantaneously when the components areinterfaced/mixed. In the most preferred embodiments, the composition is comprised of at themost about 20 mass percent (i.e., at the most about 0.2 mass fractions) of a water misciblesolvent and at the most about l mass percent (i.e., at the most about 0.01 mass fractions) ofmonomer(s). Only an interfacing or initial brief mixing/blending is required; no continuedmixing or agitation is required. The droplets remain stable in the mixture during time periodsthat are sufficiently long to allow for a polymerization of the monomer(s) to form solid polymerparticles. The size of the droplets is indicated in Figure la. Mixtures of compositions locatedoutside of the nucleation region form either (i) a single phase or (ii) unstable, aggregateddroplets. Upon polymerization, mixtures from the single-phase region may undergoprecipitation polymerization and mixtures from the unstable region may form aggregatedpolymer particles of large size distributions and/or monolithic gels. Hence, polymer particlesof narrow size distribution are formed only from mixtures located in the nucleation region.Figure lb shows the resulting particle sizes of the polymer particles formed after subjecting thetemary mixtures of PETRA, ethanol, and water in Figure la to polymerization conditions.
As mentioned above, no extensive mixing or agitation is needed for nucleation to takeplace when the composition of the components is located within the nucleation region of thephase diagram. The methods for interfacing the solution and the water phase include, but arenot limited to, batch-wise methods and flow system methods. The batch-wise methods include,but are not limited to, mixing by turbulent addition, mixing by manual inversion, mixing byautomated inversion, mixing by manual shaking, mixing by automated shaking, mixing usinga vortexer, mixing by ultrasonic treatment, mixing using a magnetic stirrer, mixing using anoverhead stirrer, mixing using a blender, mixing using a disperser device, and mixing using ahomogenizer. The flow system methods include, but are not limited to, mixing using a staticmixer, mixing using a microfluidic mixer, mixing using a micromixer, continuous-flowcapillary mixing, microfluidic mixing using Y junctions, microfluidic mixing using T junctions,and mixing using various three- or four-way intersections or connectors. Mixing devicesproduced by microfabrication or 3D-printing are useful. Industrial scale mixing devicesinclude, but are not limited to, impellers, turbines, anchors, helical ribbons, high-sheardispersers, ribbon blenders, paddle mixers, double cone blenders, static mixers, liquid whistles,dispersion mixers, mixing paddles, and continuous-flow mixers.
Figure 2 shows that there is no significant influence of the interfacing method on the resulting particle size distribution of poly(PETRA) particles.
No extended mixing/agitation is needed for the formation of the droplets When thecomposition is located in the nucleation region of the phase diagram. No stabilizer is neededfor the forrnation of droplets When the composition is located in the nucleation region of thephase diagram. The term stabilizers are here used to denote suspension stabilizers, suspendingagents, suspension agents, emulsifiers, emulsion agents, emulsifying agents, dispersants,dispersing agents, surfactants, and other agents used for similar purpose as the ones listed. Theterms are used interchangeably herein.
In the third step of the process, the polymers are formed by assembling the monomersthrough a polymerization reaction, including, but not limited to, a free-radical polymerization,a thiol-ene polymerization, an anionic polymerization, a cationic polymerization, a redox-initiated polymerization, a chain-growth polymerization, a step-growth polymerization, acondensation polymerization, a living polymerization, a reVersible-deactivation radicalpolymerization, and a reVersible addition-fragmentation chain transfer (RAFT) polymerization.Free-radical initiators useful in the present inVention include those norrnally suitable for free-radical initiation. These species include, but are not limited to, azo compounds, organicperoxides, benzoine ethers, benzyl ketals, alpha-dialkoxy acetophenones, alpha-hydroxyalkylphenones, alpha-amino alkylphenones, acyl phosphine oxides, benzophenones, and thio-xanthones. Examples of azo compounds include low molecular Weight azo initiators and macroazo initiators. Low molecular Weight azo initiators include, but are not limited to, 2,2°-azobis(2-methylbutyronitrile), 2,2 ° -azobis(2-methylpropionitrile), l , l ° -azobis(cyclohexanecarbo-nitrile), phenyl-azo-triphenylmethane, and 4,4”-azobis(4-cyanovaleric acid). Commercialproducts of this type include, but are not limited to, VAZO 52, VAZO 64, VAZO 67, andVAZO 88 initiators from DuPont. Macro azo initiators include, but are not limited to,compounds comprising polydimethylsiloxane units, such as the VPS series from Wako, andcompounds comprising polyethyleneglycol units, such as the VPE series from Wako. Examplesof peroxides include, but are not limited to, tert-butyl peroxide, cumyl peroxide, acetylperoxide, benzoyl peroxide, lauroyl peroxide, tert-butyl hydroxyperoxide, and tert-butylperbenzoate. The rate of the decomposition of peroxides may be increased by the addition oftertiary amines, such as, but not limited to, N,N-dimethylaniline. Anionic initiators useful inthe present inVention include those norrnally suitable for anionic initiation. Examples of anionicinitiators include, but are not limited to, metal alkyls such as n-butyllithium. Cationic initiatorsuseful in the present inVention include those norrnally suitable for cationic initiation. Examplesof cationic initiators include, but are not limited to, sulfuric acid, tin(IV)chloride, boron trifluoride, and iodine. Redox-initiated polymerizations use a redox pair for initiation, exemplified by, but not limited to, organic peroxides and tertiary amines, such as the benzoylperoxide and N,N-dimethyl-p-toluidine redox pair. The polymerization may be manipulated bythe addition of quenchers or inhibitors. In the case of thiol-ene polymerizations, examples ofquenchers include, but are not limited to, 3-mercaptopropionic acid and other thiols. Initiators,quenchers, and/or inhibitors are added either to the solution or to the Water phase.
To promote the polymerization, the building blocks can be exposed to a source ofenergy, such as, but not limited to, ultraviolet (UV) radiation, gamma radiation, and/or a heatsource providing an elevated temperature for a time period sufficiently long to promote thepolymerization. Preferably, the reaction is carried out at a temperature of about -30-100 °C,more preferably at a temperature of 10-90 °C, and most preferably at a temperature of 30-70°C. For polymerizations promoted by UV light, radiation in a Wavelength of about 200-400 nmis preferred. Combinations of elevated temperatures and UV light can also be applied. Figure 3shoWs the resulting particle size distributions When the polymerizations Were carried out at anelevated temperature and under the influence of UV light, respectively.
In one embodiment, the invention provides directly (i.e., after the polymerization step)a polymer particle suitable for the final application. In another embodiment the polymer particleobtained after the polymerization step is subjected to post-polymerization processing,including, but not limited to, derivatization, conjugation, decoration, modif1cation, orfunctionalization to fumish it for the final application. A range of different final applicationsexists, some of Which are shown in FigureThe invention provides in one embodiment a polymer particle suitable to be applied asa support (solid phase) in solid-phase synthesis of molecules (Figure 4a). Examples ofmolecules to be synthesized by solid-phase synthesis using the polymer particle of the inventionas a solid phase include, but are not limited to, peptides, proteins, oligonucleotides, peptidenucleic acids, carbohydrates, small organic molecules, and molecule libraries. For applicationsas a solid phase support, the polymer particle should preferentially be provided With a functionalgroup that can serve as a starting point for the solid-phase synthesis couplings. In oneembodiment, one of the monomers used as a polymer building block provides such a functionalgroup. This functional group may be used directly as the starting point for the solid-phasesynthesis. In another embodiment, the polymer particle is derivatized to provide a differentfunctional group. Examples of functional groups suitable to be used as the starting point for thesynthesis include, but are not limited to, amino groups, hydroxyl groups, and carboxyl groups.In another embodiment, a linker, a handle, or an intemal reference molecule, such as an intemal reference amino acid, is coupled to the functional group to provide a starting point for the solid- phase Synthesis. A linker or handle facilitates subsequent cleavage of the synthesized assemblyfrom the polymer particle by providing a bond that is easy to chemically cleave. Examples oflinkers and handles include, but are not limited to, the PAL linker, the HMPA linker, the HMFAlinker, the PAM linker, the XAL linker, and the BAL linker. An internal reference moleculefacilitates quantification of the cleavage yield.
In one embodiment, the invention provides a polymer particle for drug deliveryapplications by either covalently conjugating a drug to the particle, adsorbing non-covalently adrug to the particle surface, or entrapping a drug in the particle°s polymer network (Figure 4band Figure 5). The drug is either a biological drug or a conventional small molecule drug.
In one embodiment, the polymer particle is provided With a functional group suitablefor click chemistry, such as, but not limited to, the Huisgen l,3-dipolar cycloaddition, theStaudinger reaction, the thiol-ene reaction, and the Diels-Alder reaction. By a click reaction,the polymer particle is thereafter easily derivatized With a preferred molecule or used for in-situ labeling of cells and tissue.
In one embodiment of the invention, the polymer particle is derivatized With a ligand.The ligand is selected from a group of ligands including, but not limited to, nucleic acids,nucleotides, amino acids, peptides, peptide mimetics, proteins, antibodies, mini-bodies,enzymes, cell-penetrating ligands, carbohydrates, small organic molecules, boronic acids, dyes,cofactors, cell adhesion molecules, metal complexes, biotin, avidin, and streptavidin. Theligand-particle conjugate is useful for targeting to biomarkers, cells, tissue, and other biologicalmolecules and structures. The ligand-particle conjugate is useful also in biological screenings,molecular recognition studies, and tissue engineering applications. When the ligand is anaff1nity ligand, the conjugate is useful in aff1nity capture, separations, and purif1cations.
In one embodiment of the invention, the polymer particle is conjugated to, or derivatizedWith, a molecule that can be imaged by an imaging modality selected from the group of imagingmodalities including, but not limited to, fluorescent imaging, x-ray, computed tomography(CT), magnetic resonance imaging (MRI), positron emission tomography (PET), single-photonemission computed tomography (SPECT), electron microscopy, optoacoustic imaging, andmagnetic imaging. The polymer particle containing the conjugated imaging probe (can also becalled a reporter molecule), functions as a contrast agent or imaging agent during in vitro andin vivo imaging (Figure 4d).
In one embodiment, a biocompatible particle is provided through further polymerizationreactions to provide star, brush, or comb polymers on the surface of the particle. In one particular embodiment, PEG chains are conjugated to the particle to increase the biocompatibility of the particle (Figure 4e). In one embodiment, the polymer particle iscomprised of a PEG-containing monomer. In another embodiment, the polymer particle isderiVatized With a natural polymer including, but not limited to, chitosan, chitin, alginate,gelatin, starch, carrageenan, dextran, and cyclodextrins.
In one embodiment, the inVention provides a polymer particle suitable for 2D- and 3D-printing applications.
Combinations of any of the embodiments are possible. For example, in oneembodiment, a polymer particle is derivatized With a drug, an imaging probe, and an aff1nityligand to provide a particle capable of targeted theranostics (i.e., combined therapy anddiagnosis). The applications of the polymer particles of the inVention are not limited to the embodiments listed here.
EXAMPLES Example lIdentification of Composítíons Provídíng Nucleated Droplets and Polymerízed Partícles Firstly, a temary PETRA-ethanol-Water phase diagram Was constructed foridentification of the nucleation region. Water and ethanol Were purged With nitrogen gas priorto use. Temary mixtures (10 mL) of PETRA, ethanol, and Water Were prepared by interfacingVolumes (1-50 vol%) of a solution of PETRA (2.5 mM-150 mM) in ethanol With Volumes (50-99 vol%) of Water. The ethanolic solution Was added to the Water phase and the two liquidsWere manually interfaced by inVerting (shaking) the sample approximately 20 times. Theresulting mixtures Were inspected and subjected to dynamic light scattering (DLS) analysisusing a Nanotrac Ultra Particle Size Analyzer from Mictrotrac (Montgomeryyille, PA, USA)to determine the size distribution of the droplets. The mean droplet size Was calculated basedon intensity using the Rayleigh-Debye theory (n = 10). The mass fractions of ethanol andPETRA, respectively, in each of the temary mixtures Were calculated. The calculated data Werecombined With the DLS data and plotted in a phase diagram (Figure la). Secondly, mixturesfor polymerization testing in small scale Were prepared following the same procedure, exceptthat the Water phases Were preheated to 60 °C and the ethanolic solutions included AIBN (40mM) used as a free-radical initiator. Polymerizations Were carried out for 6 h in a Water bath set at 60 °C and the samples Were cooled to room temperature before characterization. The resulting mixtures Were inspected and analyzed by DLS. The data Were plotted in a phase diagram (Figure lb).
Example 2Synthesis of Poly(PE T RA) Particles;Demonstration of the Applicabilitj/ of Different Interfacing Methods A solution containing PETRA (0.04 M) and AIBN (0.08 M) in ethanol Was prepared.The ethanol used had previously been purged With nitrogen gas for 10 min. The solution (lvolume part) Was then added to preheated (60 °C) Water that had previously been purged Withnitrogen gas for l h (39 volume parts). The solution and the Water phase Were interfaced byapplying either (i) manual shaking (20 inversions); (ii) an IKA Labortechnik Eurostar digitaloverhead stirrer (IKA-Werke Gmbh & Co., Staufen, Gerrnany) equipped With a Heidolph TR20 radial floW impeller operating at 700 rpm for 3 min; (iii) a model Dl25 basic dispersingdevice equipped With an S25N-25F dispersing element (IKA-Werke Gmbh & Co., Staufen,Germany) operating at 8000 rpm for l min; or (iv) a Bandelin Sonoplus ultrasonic homogenizerequipped With a VS70T titanium alloy probe (Bandelin Gmbh, Berlin, Germany) operating at20 W for 6 x 10 s. The total volume of each mixture Was 500 mL. Therrnolytically initiatedpolymerizations Were carried out in a 60 °C Water bath for 6 h. The polymerized mixtures Werecentrifuged (9 500 rpm, 2 h). The supematants Were discarded and the particles Were retained.The particles Were incubated repeatedly first With ethanol, then With Water, and finally againWith ethanol. After each incubation, the samples Were centrifuged (9 500 rpm, 2 h) anddecanted. The absorbance of the supematants Was measured at 210 nm. Extractions Wererepeated until the absorbance of the supematants Was < 0.05 absorbance units. Finally, theparticles Were dried in vacuo ovemight. The dried particles Were dissolved in Water for DLSanalysis (Table l, Figures 2a-d). The mean particle size Was calculated based on intensity usingthe Rayleigh-Debye theory. The polydispersity index Was calculated as dv/ dN, Where dv and dNare the mean particle sizes based on volume and numbers, respectively, calculated using the Lorenz-Mie theory.
Table 1. Influence of Interfacing Method on Size and Polydispersity of Poly(PETRA) Particles (DLS , n=30) Interfacing Method Mean Particle Size i SD (nm) Mean Polydispersity Index i SDManual shaking (20 inversions) 262 i 21 1.27 i 0.11Overhead stirrer (700 rpm, 3 min) 248 i 25 1.36 i 0.18Disperser/homogenizer (8 000 rpm, 1 min) 258 i 16 1.29 i 0.16Ultrasonic homogenizer (6 X 10 s, 20 W) 258 i 18 1.33 i 0.Example 3Synthesis of Poly(PE T RA ) Particles;Demonstration of the Applicabilitj/ of Dzflerent Free-Radical Generation Methods A solution Was prepared by dissolving PETRA (0.04 M) and AIBN (0.04 M) in ethanolthat had previously been purged With nitrogen gas for 10 min. The solution (l volume part) Wasthen added to Water that had previously been purged With nitrogen gas for l h (9 volume parts).Preheated (60 °C) Water Was used for therrnolytically initiated polymerizations and Water ofroom temperature Was used for photolytically initiated polymerizations. The solution and theWater phase Were interfaced by inverting the sample manually (shaking) approximately 20times. The total volume of the mixture Was 250 mL. Therrnolytically initiated polymerizationsWere carried out in a 60 °C Water bath for 6 h. Photolytically initiated polymerizations Werecarried out under a DYMAX UV (350 nm) curing flood lamp model PC-2000 (Torrington, CT)for 2 h. The polymerized mixtures Were centrifuged (9 500 rpm, 2 h) and the supematants Werediscarded. The particles Were incubated repeatedly first With ethanol, then With Water, andfinally again With ethanol. After each incubation, the samples Were centrifuged (9 500 rpm, 2h) and decanted. The absorbance of the supematants Was measured at 210 nm. Extractions Wererepeated until the absorbance of the supematant Was < 0.05 absorbance units. Finally, theparticles Were dried in vacuo ovemight. The dried particles Were dissolved in Water for DLS analysis (Table 2, Figures 3a,b).
Table 2. Influence of Polymerization Conditions on Size and Polydispersity of Particles (DLS, n=10) Polymerization Conditions Mean Particle Size i SD (nm) Mean Polydispersity Index i SD 60 °C (Water bath), 6 h 415 i 32 1.23 i 0.16350 nm (UV flood lamp), 2 h 427 i 40 1.23 i 0.18ExampleSynthesis of Polj/(PE TRA-co-Allylamine) Particles A solution Was prepared by dissolving PETRA (0.04 M), allylamine (0.l55 M) andAIBN (0.04 M) in ethanol that had previously been purged With nitrogen gas for 10 min. Thesolution (l volume part) Was added to Water that had previously been purged With nitrogen gasfor l h (9 volume parts). The solution and the Water phase Were interfaced by manual shaking(20 inversions). The total volume of the mixture Was 250 mL. A photolytically initiatedpolymerization Was carried out under a DYMAX UV (350 nm) curing flood lamp model PC-2000 (Torrington, CT) for 2 h. The polymerized mixture Was centrifuged (9 500 rpm, 2 h) and the supematant Was discarded. The particles Were incubated repeatedly first With ethanol, thenWith Water, and finally again With ethanol. After each incubation, the samples Were centrifuged(9 500 rpm, 2 h) and decanted. The absorbance of the supematant Was measured at 210 nm.Extractions Were repeated until the absorbance of the supematant Was < 0.05 absorbance units.Finally, the particles Were dried in vacuo ovemight. The particles tested positively in Kaiser°squalitative ninhydrin test, indicating the presence of free amino groups.
Example 4 demonstrates that the invention provides particles With free amino groups, Which are suitable to serve as starting points for couplings/derivatizations.
Example 5Synthesis of P0ly(PE T RA-co-MAA ) Particles A solution Was prepared by dissolving PETRA (0.04 M), methacrylic acid (MAA; 0.32M), and AIBN (0.04 M) in ethanol that had previously been purged With nitrogen gas for 10min. The solution Was then added to Water that had previously been purged With nitrogen gasfor l h. The solution and the Water phase Were interfaced by manual shaking (20 inversions).The total volume of the mixture Was 250 mL. A photolytically initiated polymerization Wascarried out under a DYMAX UV (350 nm) curing flood lamp model PC-2000 (Torrington, CT)for 2 h. The polymerized mixture Was centrifuged (9 500 rpm, 2 h) and the supematant Wasdiscarded. The particles Were incubated repeatedly first With ethanol, then With Water, andfinally again With ethanol. After each incubation, the samples Were centrifuged (9 500 rpm, 2h) and decanted. The absorbance of the supematant Was measured at 210 nm. Extractions Wererepeated until the absorbance of the supematant Was < 0.05 absorbance units. Finally, the particles Were dried in vacuo ovemight.
Example 6Synthesis of P0ly(PE T RA-c0-4- VBA) ParticlesA solution Was prepared by dissolving PETRA (0.04 M), 4-vinylbenzoic acid (4-VBA;0.04 M) and AIBN (0.04 M) in ethanol that had previously been purged With nitrogen gas for10 min. The solution Was then added to Water that had previously been purged With nitrogengas for l h. The solution and the Water phase Were interfaced by manual shaking (20 inversions).The total volume of the mixture Was 250 mL. A photolytically initiated polymerization Was carried out under a DYMAX UV (350 nm) curing flood lamp model PC-2000 (Torrington, CT) for 2 h. The polymerized mixture Was centrifuged (9 500 rpm, 2 h) and the supematant Wasdiscarded. The particles Were incubated repeatedly first With ethanol, then With Water, andfinally again With ethanol. After each incubation, the sample Was centrifuged (9 500 rpm, 2 h)and decanted. The absorbance of the supematant Was measured at 210 nm. Extractions Wererepeated until the absorbance of the supematant Was < 0.05 absorbance units. Finally, theparticles Were dried in vacuo ovemight.
Examples 5 and 6 demonstrate that the invention provides particles With free carboxyl groups, Which are suitable to serve as starting points for couplings/derivatizations.
Example 7Synthesis of P0ly( T RIM-co-HEMA ) Particles A solution Was prepared by dissolving trimethylolpropane trimethacrylate (TRIM; 0.04M), 2-hydroxyethyl methacrylate (0.04 M), and AIBN (0.04 M) in ethanol that had previouslybeen purged With nitrogen gas for 10 min. The solution Was then added to Water that hadpreviously been purged With nitrogen gas for l h. The solution and the Water phase Wereinterfaced by manual shaking (20 inversions). The total volume of the mixture Was 100 mL. Aphotolytically initiated polymerization Was carried out under a DYMAX UV (350 nm) curingflood lamp model PC-2000 (Torrington, CT) for 2 h. The polymerized mixture Was centrifuged(9 500 rpm, 2 h) and the supematant Was discarded. The particles Were incubated repeatedlyfirst With ethanol, then With Water, and finally again With ethanol. After each incubation, thesample Was centrifuged (9 500 rpm, 2 h) and decanted. The absorbance of the supematant Wasmeasured at 210 nm. Extractions Were repeated until the absorbance of the supematant Was< 0.05 absorbance units. Finally, the particles Were dried in vacuo ovemight.Example 7 demonstrates that the invention provides particles With free hydroxyl groups, Which are suitable to serve as starting points for couplings/derivatizations.
Example 8Post-Polymerization Derivatization of P0ly(PE T RA) Particles with the PAL LinkerPoly(PETRA) particles Were prepared as described in Example 3. Fmoc-Gly-OH (0.595g, 2 mmol) Was dissolved in DMF (l mL) and added to the dried poly(PETRA) particles (200mg). N,N”-diisopropylcarbodiimide (DIPCDI; 0.252 g, 2 mmol) in DMF (l mL) and 4-dimethylaminopyridine (DMAP; 25 mg, 0.2 mmol) in DMF (l mL) Were added. The sample Was placed on a rotating shaker for 2 days. The particles Were centrifuged and repetitivelysuspended in DMF (5 times). Deprotection Was carried out by treatment With piperidine-DMF(2 x 10 min). The particles Were again Washed With DMF. Qualitative ninhydrin test (Kaisertest) Was positive. The PAL linker Was coupled by adding Fmoc-PAL-OH (0.99 g, 2 mmol) inDMF (3 mL), DIPCDI (0.252 g, 2 mmol) in DMF (1 mL) and l-hydroxybenzotriazole (HOBt;0.306 g, 2 mmol) in DMF (3 mL). The sample Was placed on a rotating shaker for 2 days. Theparticles Were centrifuged (9 500 rpm, 1 h) and Washed repeatedly With DMF and finally Withmethanol.
Example 8 demonstrates that the carboxyl-containing poly(PETRA) particles can be derivatizedafter polymerization to provide amino groups suitable for further derivatizations/couplings. Theparticles of Example 8, functionalized With a cleavable linker, are suitable as a solid-phase synthesis support.
Example 9Post-Polymerízatíon Derívatízatíon of Polj/(PE T RA-co-Allylamíne) Partícles with FIT CPoly(PETRA-co-allylamine) particles Were prepared as described in Example 4. FITC(fluorescein isothiocyanate; 5 mg) Was dissolved in ethanol (5 mL) and added to driedpoly(PETRA-co-allylamine) particles (100 mg). The sample Was placed on a rotating shakerfor 2 days. The particles Were centrifuged (9 500 rpm, 1 h) and Washed repeatedly With ethanol until the supematant Was colorless.
Example 10Post-Polymerízatíon Derívatízatíon of P0ly(PE T RA-co-Allylamíne) Partícleswith a Radíopaque DerívatíveN-succinimidyl 2,3,5-triiodobenzoate Was synthesized in 85% yield by reacting N-hydroxysuccinimide (l.266 g, 11 mmol), 2,3,5-triiodobenzoic acid (1.998 g, 10 mmol), and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (2,108 g, 11 mmol) in methylene chloride (200mL). After 100 h, the solution Was extracted With Water (3 times) and saturated aqueous NaCl(3 times). The organic phase Was dried over MgSO4, evaporated, and dried in vacuum.Poly(PETRA-co-allylamine) particles Were prepared as described in Example 4. The particlesWere mixed With N-succinimidyl 2,3,5-triiodobenzoate in DMF. The particles Were centrifuged (9 500 rpm, 1 h) and Washed repeatedly With DMF and finally methanol.
Examples 9 and 10 demonstrate that the particles of the invention can be derivatizedWith fluorescent and radiopaque derivatives, making the particles suitable as imaging probes and contrast agents.
Example llPost-Polymerízatíon Derívatízatíon of P0ly(PE T RA-co-Allylamíne) Partícles with PE G Poly(PETRA-co-allylamine) particles Were prepared as described in Example 4. Theparticles (10 mg) Were dissolved in Water (l mL). Polyethylene glycol N-succinimidylpropionate (10 mg) Were dissolved in Water (0.25 mL) and added to the particles. The sampleWas placed on a rotating shaker for l day. The particles Were centrifuged (9 500 rpm, l h) andWashed repeatedly With methanol.
Example ll demonstrates that the particles of the invention can be derivatized With PEG, providing particles suitable for biomedical and medical applications.
Example 12Synthesis of Po1y(Trimethy1o1propane E thoxylate T ríacrylate) PartíclesThree different solutions, each containing a branched PEG-containing cross-linker (0.02M; Table 3) and AIBN (0.04 M), Were prepared by dissolving the respective cross-linker inethanol. Each solution (l volume part) Was then added to Water (19 Volume parts; previouslypurged With nitrogen gas for l h) and interfacing Was carried out by inverting the samplesmanually (shaking) approximately 20 times. The total volume of each mixture Was 1000 mL.Therrnolytically initiated polymerizations Were carried out in a 60 °C Water bath for 6 h. Thepolymerized reaction mixtures Were analysed by DLS, showing mean particle size and polydispersity index as indicated in TableTable 3. Composition, Size, and Polydispersity of Po1y(Trimethy1o1propane Ethoxylate Triacrylate) Particles(DLS, n=20) CmSSLínker Mea: gårëcrlgelfize Mean Polyiissrlašrsity IndexTrimethylolpropane Ethoxylate (1 EO/OH) Triacrylate 274 i 17 1.35 i 0.14Trimethylolpropane Ethoxylate (7/3 EO/OH) Triacrylate 162 i 4 1.18 i 0.05Trimethylolpropane Ethoxylate (14/ 3 EO/OH) Triacrylate 165 i 3 1.17 i 0.Example 13Synthesis of Poly( T rimethylolløropane Ethoxylate T riacrylate) Particles;Demonstration of the Applicabilitj/ of Various Interfacing Methods Solutions Were prepared by dissolving trimethylolpropane ethoxylate (7/3 EO/OH)triacrylate (0.0l M) and AIBN (0.02 M) in ethanol. Each solution (l volume part) Was thenadded to Water (9 volume parts; previously purged With nitrogen gas for l h). The solutions andthe Water phases Were interfaced by applying either (i) manual shaking (20 inversions); (ii) anIKA Labortechnik Eurostar digital overhead stirrer (IKA-Werke Gmbh & Co., Staufen,Gerrnany) equipped With a Heidolph TR 20 radial floW impeller operating at 1000 rpm for 30s; (iii) a model Dl25 basic dispersing device equipped With an S25N-25F dispersing element(IKA-Werke Gmbh & Co., Staufen, Gerrnany) operating at 8000 rpm for 30 s. The total volumeof each mixture Was 100 mL. Photolytically initiated polymerizations Were carried out under aDYMAX UV (350 nm) curing flood lamp model PC-2000 (Torrington, CT) for 2 h. Thepolymerized reaction mixtures Were analysed by DLS (n=20), shoWing mean particle size and polydispersity index as indicated in TableTable 4. Influence of Interfacing Method on Size and Polydispersity of Poly(Trimethylolpropane EthoxylateTriacrylate) Particles Interfacing Method Mean Particle Size i SD (nm) Mean Polydispersity Index i SDManual shaking (20 inversions) 170 i 4 1.22 i 0.11Overhead stirrer (1000 rpm, 30 s) 177 i 8 1.29 i 0.12Disperser/homogenizer (8 000 rpm, 30 s) 188 i 5 1.20 i 0.09ExampleSynthesis of Poly( T rimethylolløropane E thoxylate T riacrylate-co-HEMA ) Particles A solution Was prepared by dissolving trimethylolpropane ethoxylate (7/3 EO/OH)triacrylate (0.0l8 M), 2-hydroxyethyl methacrylate (0.0l8 M), and AIBN (0.0l8 M) in ethanol.The solution (l volume part) Was then added to Water (9 volume parts; previously preheated to60 °C and purged With nitrogen gas for l h). The solution and the Water phase Were interfacedby inverting the sample manually (shaking) approximately 20 times. The total volume of themixture Was 250 mL. A therrnolytically initiated polymerization Was carried out in a 60 °CWater bath for 6 h. The polymerized reaction mixture Was analysed by DLS (intensity mode;n=l0), shoWing a mean particle size of 366 i l7 nm.
Example 14 demonstrates that the invention provides particles With free hydroxyl groups, Which are suitable to serve as starting points for couplings/derivatizations.
Example 15Synthesis of P0ly(PE T RA-co-PE GMAA ) A solution Was prepared by dissolving PETRA (0.04 M), poly(ethylene glycol)methacrylate (PEGMAA; 0.08 M), and AIBN (0.08 M) in ethanol that had previously beenpurged With nitrogen gas. The solution (1 Volume part) Was then added to Water (39 Volumeparts; previously preheated to 60 °C and purged With nitrogen gas for 1 h). The solution andthe Water phase Were interfaced by inverting the sample manually (shaking) approximately 20times. The total Volume of the mixture Was 500 mL. A therrnolytically initiated polymerizationWas carried out in a 60 °C Water bath for 6 h. The polymerized mixture Was centrifuged (9 500rpm, 2 h) and the supematant Was discarded. The particles Were incubated repeatedly first Withethanol, then With Water, and finally again With ethanol. After each incubation, the sample Wascentrifuged (9 500 rpm, 2 h) and decanted. The absorbance of the supematant Was measured at210 nm. Extractions Were repeated until the absorbance of the supematant Was < 0.05absorbance units. Finally, the particles Were dried in vacuo ovemight. The dried particles Weredissolved in Water for DLS analysis (intensity mode; n=l0), shoWing a mean particle size of250 i 15 nm.
Examples 12-15 demonstrate that the method of the inVention can be applied to thepreparation of PEG-containing particles. These particles are biocompatibility and suitable for biomedical and medical applications.
Example 16Synthesis of Polymer Partícles by T híol-Ene Polymerízatíon of PE T MP and TA TA TOA solution Was prepared by dissolving pentaerythritol tetrakis(3-mercaptopropionate)(PETMP; 20 mM), 1,3,5-triallyl-1,3,5-triazine-2,4,6(1H,3H,5H)-trione (TATATO; 26 mM),and AIBN (8 mM) in ethanol. One Volume part of the solution Was added to 39 Volume partsof 60 °C pre-heated Water. The solution and the Water phase Were interfaced by manual shaking(20 inversions). Polymerization Was carried out at 60 °C for 2 h. The polymerized reaction mixture Was analyzed by DLS, showing a mean particle size of 490 i 35 nm.
Example 17Synthesis 0f Polymer Partícles by T híol-Ene Polymerízatíon 0f PE T MP and PETRAA solution Was prepared by dissolving pentaerythritol tetrakis(3-mercaptopropionate)(PETMP; 20 mM), PETRA (26 mM), and AIBN (8 mM) in ethanol. One Volume part of thesolution Was added to 39 volume parts of 60 °C pre-heated Water. The solution and the Waterphase Were interfaced by manual shaking (20 inversions). Polymerization Was carried out at 60°C for 2 h. The polymerized reaction mixture Was analyzed by DLS, showing a mean particle size of 348 i 48 nm.
Example 18Synthesis 0f Polymer Partícles by T híol-Ene Polymerízatíon 0fPE T MP and PETRA under the Influence 0f a QuencherA solution Was prepared by dissolving pentaerythritol tetrakis(3-mercaptopropionate)(PETMP; 20 mM), PETRA (26 mM), and AIBN (8 mM) in ethanol. One Volume part of thesolution Was added to 39 Volume parts of 60 °C pre-heated Water. The solution and the Waterphase Were interfaced by manual shaking (20 inversions). Polymerization Was carried out at 60°C during a total time of 2 h. After 50 min, 3-mercaptopropionic acid Was added to a finalconcentration of 2 mM in the mixture. The polymerized reaction mixture Was analyzed by DLS, showing a mean particle size of 280 i 17 nm.
Example 19Synthesis 0f Polymer Partícles by T híol-Ene Polymerízatíon 0fPETMP, PETRA, and benzyl methacrylate A solution Was prepared by dissolving pentaerythritol tetrakis(3-mercaptopropionate)(PETMP; 1.25 mM), PETRA (2.5 mM), benzyl methacrylate (5 mM), and AIBN (5 mM) inethanol. One volume part of the solution Was added to 1.5 Volume parts of Water of roomtemperature. The solution and the Water phase Were interfaced by manual shaking (20inversions). The total Volume Was 500 mL. Polymerization Was carried out at 60 °C for 2 h.The polymerized reaction mixture Was analyzed by DLS, shoWing a mean particle size of 430i 14 nm.
Examples 16-19 demonstrate the preparation of particles by thiol-ene polymerization.
Claims (12)
1. A polymer particle of a size of about 10 to 1000 nm prepared from a nucleated composition, formedspontaneously and instantaneously in absence of surfactant, stabilizer, or dispersant and Without extended agitation, and comprising a monomer of the following forrnula (1):
2. Wherein; (a) X is -CH2-, -O-CHz-CHr, -O-CH2~CH(CH3)-, or -O-CH(CH3)-CH2-; (b) Y is -O-C(O)-CH=CH2, -O-C(O)-C(CH3)=CH2, -NH-C(O)-CH=CHz,-NH-C(O)-C(CH3)=CHz, -O-CH=CHz, -O-CH2-CH=CH2, -CH=CHz,-CHz-CH=CHz, -O-C(O)-CHz-CHz-SH, -NH-C(O)-CHz-CHz-SH, or SH; (c) Z is -CHg-Xp-Y, a hydrogen, a functional group, an alkyl group, or a functionalized alkylgroup; and (d) each of l, m, n, and p is independently a number in the range 0-2. The polymer particle of claim 1 Wherein the nucleated composition further comprises a monomer.
3. The polymer particle of claim 2 Wherein said monomer contains a functional group selected fromthe group consisting of the amino group, the hydroxyl group, the carbonyl group, the aldehyde group,the haloforrnyl group, the carboxyl group, the carboxylate group, the ester group, the carbonate estergroup, the amide group, the imine group, the imide group, the azide group, the azo group, thehydrocarbyl group, the aromate group, the halo group, the cyanate group, the nitrate group, the nitrilegroup, the nitrite group, the nitro group, the nitroso group, the pyridyl group, the oxime group, thethiol group, the sulfide group, the disulf1de group, the sulfinyl group, the sulfonyl group, the sulfinogroup, the sulfo group, the thiocyanate group, the thioketone group, the thio ester group, thephosphino group, the phosphono group, the phosphate group, the borono group, the boronate group, the borino group, and the borinate group.
4. The polymer particle of any of the previous claims Wherein the nucleated composition is formed byinterfacing a Water phase and a solution comprising said monomer(s) dissolved in a Water-miscible solVent.
5. A process for preparing a polynier particle of about 10 to 1000 nn1, coniprising the steps: (a) providing a n1onon1er of the following forrnula (1): (1)Wherein; (i) X is -CH2-, -O-CHg-CHT, -O-CH2-CH(CH3)-, or -O-CH(CH3)-CH2-; (ii) Y is -O-C(O)-CH=CH2, -O-C(O)-C(CH3)=CH2, -NH-C(O)-CH=CHz,-NH-C(O)-C(CH3)=CH2, -O-CH=CH2, -O-CH2-CH=CH2, -CH=CHz,-CHz-CH=CHz, -O-C(O)-CHz-CHz-SH, -NH-C(O)-CHz-CHz~SH, or SH; (iii) Z is -CHg-Xp-Y, a hydrogen, a functional group, an alkyl group, or afunctionalized alkyl group; and (iv) each of l, ni, n, and p is independently a number in the range 0-(b) dissolVing said n1onon1er in a Water-niiscible solVent, forrning a solution coniprising then1onon1er; (c) interfacing said solution and a Water phase, in absence of surfactant, stabilizer, or dispersantand Without extended agitation, to forrn a niixture in Which spontaneous and instantaneousforrnation of nucleated droplets con1prising said n1onon1er takes place; and (d) polynierizing said n1onon1er by a polynierization reaction.
6. The process of claini 5 Wherein said solution further coniprises a n1onon1er.
7. The process of claini 6 Wherein said n1onon1er contains a functional group selected from the groupconsisting of the an1ino group, the hydroxyl group, the carbonyl group, the aldehyde group, thehaloforrnyl group, the carboxyl group, the carboxylate group, the ester group, the carbonate ester group,the an1ide group, the in1ine group, the in1ide group, the azide group, the azo group, the hydrocarbylgroup, the aron1ate group, the halo group, the cyanate group, the nitrate group, the nitrile group, thenitrite group, the nitro group, the nitroso group, the pyridyl group, the oxinie group, the thiol group, thesulf1de group, the disulf1de group, the sulfinyl group, the sulfonyl group, the sulfino group, the sulfo group, the thiocyanate group, the thioketone group, the thio ester group, the phosphino group, thephosphono group, the phosphate group, the borono group, the boronate group, the borino group, andthe borinate group.
8. The process of claim 5 Wherein said Water-miscible solvent is selected from a group of solventsconsisting of methanol, ethanol, l,2-ethanediol, l-propanol, 2-propanol, l,2-propanediol, 1,3-propanediol, l-butanol, 2-butanol, l,2-butanediol, l,3-butanediol, l,4-butanediol, l-pentanol, 2-pentanol, 3-pentanol, l,2-pentanediol, l,3-pentanediol, 2,3-pentanediol, 2,4-pentanediol, l,4-pentanediol, l,5-pentanediol, glycerol, erythritol, pentaerythritol, furfuryl alcohol, diethylene glycol,triethylene glycol, tetraethylene glycol, pentaethylene glycol, acetonitrile, N,N-dimethylforrnamide,dimethyl sulfoxide, acetone, acetic acid, acetaldehyde, hexamethylphosphoric triamide,dimethoxyethane, l,4-dioxane, N-methyl-2-pyrrolidone, pyridine, tetrahydrofuran, or combinations thereof.
9. The process of claim 5 Wherein said interfacing step is augmented by a mixing procedure selectedfrom the group of mixing procedures comprising batch-Wise mixing methods including mixing byturbulent addition, mixing by manual inversion, mixing by automated inversion, mixing by manualshaking, mixing by automated shaking, mixing using a vortexer, mixing by ultrasonic treatment, mixingusing a magnetic stirrer, mixing using an overhead stirrer, mixing using a blender, mixing using adisperser device, and mixing using a homogenizer, flow system mixing methods including mixing usinga static mixer, mixing using a microfluidic mixer, mixing using a micromixer, continuous-flow capillarymixing, microfluidic mixing using Y junctions, microfluidic mixing using T junctions, and mixing usingvarious three- or four-Way intersections or connectors, mixing by devices produced by microfabricationor 3D-printing, and industrial scale mixing devices including impellers, turbines, anchors, helicalribbons, high-shear dispersers, ribbon blenders, paddle mixers, double cone blenders, static mixers, liquid Whistles, dispersion mixers, mixing paddles, and continuous-flow mixers.
10. l0. The process of claim 5 Wherein said polymerization reaction is a free-radical polymerization.
11. ll. The process of claim 5 Wherein said polymerization reaction is a thiol-ene polymerization.
12. The process of any of claims 5-ll Wherein said mixture is comprised of at the most about 20 mass percent of the Water miscible solvent and at the most about l mass percent of the monomer.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1830166A SE544611C2 (en) | 2018-05-18 | 2018-05-18 | Polymer particles |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1830166A SE544611C2 (en) | 2018-05-18 | 2018-05-18 | Polymer particles |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE1830166A1 SE1830166A1 (en) | 2019-11-19 |
| SE544611C2 true SE544611C2 (en) | 2022-09-20 |
Family
ID=68836159
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE1830166A SE544611C2 (en) | 2018-05-18 | 2018-05-18 | Polymer particles |
Country Status (1)
| Country | Link |
|---|---|
| SE (1) | SE544611C2 (en) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5080994A (en) * | 1989-10-23 | 1992-01-14 | Xerox Corporation | Processes for the preparation of particles |
| JPH08259608A (en) * | 1995-03-24 | 1996-10-08 | Japan Synthetic Rubber Co Ltd | Method for producing crosslinked polymer particles |
| US20030204013A1 (en) * | 2002-04-19 | 2003-10-30 | Shanti Swarup | Highly crosslinked polymer particles and coating compositions containing the same |
| US20090053272A1 (en) * | 2005-05-10 | 2009-02-26 | Basf Se | Method for producing polymer nanoparticles |
| WO2009032266A2 (en) * | 2007-09-04 | 2009-03-12 | University Of Florida | Dispersions of microparticles and microgels in hydrogels for drug delivery |
| CN105315408A (en) * | 2015-11-19 | 2016-02-10 | 北京理工大学 | Synthetic method for molecular imprinting material and application of molecular imprinting material in separation of solanesol in tobacco leaves |
| US20160330954A1 (en) * | 2014-04-22 | 2016-11-17 | Valspar Sourcing, Inc. | Coating Composition with Sustained Release |
-
2018
- 2018-05-18 SE SE1830166A patent/SE544611C2/en unknown
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5080994A (en) * | 1989-10-23 | 1992-01-14 | Xerox Corporation | Processes for the preparation of particles |
| JPH08259608A (en) * | 1995-03-24 | 1996-10-08 | Japan Synthetic Rubber Co Ltd | Method for producing crosslinked polymer particles |
| US20030204013A1 (en) * | 2002-04-19 | 2003-10-30 | Shanti Swarup | Highly crosslinked polymer particles and coating compositions containing the same |
| US20090053272A1 (en) * | 2005-05-10 | 2009-02-26 | Basf Se | Method for producing polymer nanoparticles |
| WO2009032266A2 (en) * | 2007-09-04 | 2009-03-12 | University Of Florida | Dispersions of microparticles and microgels in hydrogels for drug delivery |
| US20160330954A1 (en) * | 2014-04-22 | 2016-11-17 | Valspar Sourcing, Inc. | Coating Composition with Sustained Release |
| CN105315408A (en) * | 2015-11-19 | 2016-02-10 | 北京理工大学 | Synthetic method for molecular imprinting material and application of molecular imprinting material in separation of solanesol in tobacco leaves |
Non-Patent Citations (6)
| Title |
|---|
| ARSHADY, R. Suspension, emulsion, and dispersion polymerization: A methodological survey. Colloid and polymer science, 1992, 270.8: 717-732. * |
| BARKER, Emily M.; BUCHANAN, J. Paige. Thiol-ene polymer microbeads prepared under high-shear and their successful utility as a heterogeneous photocatalyst via C 60-capping. Polymer, 2016, 92: 66-73. * |
| DURHAM, Olivia Z., et al. Radical Mediated Thiol-Ene Emulsion Polymerizations. Macromolecules, 2017, 50.3: 775-783. * |
| GADZALA-KOPCIUCH, Renata; RICANYOVA, Julia; BUSZEWSKI, Boguslaw. Isolation and detection of steroids from human urine by molecularly imprinted solid-phase extraction and liquid chromatography. Journal of Chromatography B, 2009, 877.11-12: 1177-1184. * |
| KEMPE, Henrik; KEMPE, Maria. QSRR analysis of â-lactam antibiotics on a penicillin G targeted MIP stationary phase. Analytical and bioanalytical chemistry, 2010, 398.7-8: 3087-3096. * |
| KEMPE, Henrik; PUJOLRAS, Anna Parareda; KEMPE, Maria. Molecularly imprinted polymer nanocarriers for sustained release of erythromycin. Pharmaceutical research, 2015, 32.2: 375-388. * |
Also Published As
| Publication number | Publication date |
|---|---|
| SE1830166A1 (en) | 2019-11-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Canning et al. | A critical appraisal of RAFT-mediated polymerization-induced self-assembly | |
| Graham et al. | One-pot synthesis of branched poly (methacrylic acid) s and suppression of the rheological “polyelectrolyte effect” | |
| Gao | Development of star polymers as unimolecular containers for nanomaterials | |
| Liu et al. | Conformation–function relationships for the comb-shaped polymer pOEGMA | |
| Zhang et al. | Morphological stabilization of block copolymer worms using asymmetric cross-linkers during polymerization-induced self-assembly | |
| Jones et al. | How do spherical diblock copolymer nanoparticles grow during RAFT alcoholic dispersion polymerization? | |
| Truong et al. | Surfactant-free RAFT emulsion polymerization using a novel biocompatible thermoresponsive polymer | |
| An et al. | Synthesis of architecturally well-defined nanogels via RAFT polymerization for potential bioapplications | |
| CZ20002747A3 (en) | Novel surface-active copolymers based on methylidene malonate | |
| Zepon et al. | Glyco-nanoparticles made from self-assembly of maltoheptaose-block-poly (methyl methacrylate): Micelle, reverse micelle, and encapsulation | |
| Imaz et al. | N‐vinylcaprolactam‐based microgels: Effect of the concentration and type of cross‐linker | |
| Klinger et al. | Enzymatically degradable nanogels by inverse miniemulsion copolymerization of acrylamide with dextran methacrylates as crosslinkers | |
| Schlachet et al. | Chitosan-graft-poly (methyl methacrylate) amphiphilic nanoparticles: Self-association and physicochemical characterization | |
| Zhang et al. | Dopamine-functionalized pectin-based Pickering emulsion as an oral drug delivery system | |
| Gohy | Metallo-supramolecular block copolymer micelles | |
| Rymaruk et al. | RAFT dispersion polymerization of benzyl methacrylate in silicone oil using a silicone-based methacrylic stabilizer provides convenient access to spheres, worms, and vesicles | |
| Jiang et al. | Aqueous solution behaviour of novel water-soluble amphiphilic copolymers with elevated hydrophobic unit content | |
| Etchenausia et al. | Cationic thermoresponsive poly (N-vinylcaprolactam) microgels synthesized by emulsion polymerization using a reactive cationic macro-RAFT agent | |
| Ishizuka et al. | Polymeric nanocomposites based on high aspect ratio polymer fillers: Simultaneous improvement in tensile strength and stretchability | |
| Brito et al. | Film formation of Alkali Soluble Resin (ASR) stabilized latexes | |
| Walther et al. | Bis-hydrophilic block terpolymers via RAFT polymerization: toward dynamic micelles with tunable corona properties | |
| Georgiou et al. | Degradable diblock copolymer vesicles via radical ring-opening polymerization-induced self-assembly in aqueous media | |
| Ishizuka et al. | Synthesis of Hydrophobic Block Copolymer Nanoparticles in Alcohol/Water Stabilized by Poly (methyl methacrylate) via RAFT Dispersion Polymerization-Induced Self-Assembly | |
| Sugihara et al. | Synthesis of various poly (2-hydroxyethyl vinyl ether)-stabilized latex particles via surfactant-free emulsion polymerization in water | |
| Chen et al. | UV-cross-linked polymer nanostructures with preserved asymmetry and surface functionality |